AB 1286: Pharmacy.
- Session Year: 2023-2024
- House: Assembly
- Latest Version Date: 2023-10-08
Current Status:
Passed
(2023-10-08: Chaptered by Secretary of State - Chapter 470, Statutes of 2023.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Enacted
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. Existing law authorizes the board to appoint an executive officer to exercise the powers and perform the duties delegated by the board. A violation of the Pharmacy Law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would require a pharmacist-in-charge or pharmacist on duty to immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The bill would require store management to take immediate and reasonable steps to address and resolve those conditions, and, if those conditions are not resolved within 24 hours, would require the pharmacist-in-charge or pharmacist on duty to ensure the board is notified. The bill would require the executive officer, upon a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, to issue a cease and desist order, as specified. The bill would make a failure to comply with the cease and desist order unprofessional conduct for a pharmacy corporation.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would require a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would prohibit the board from taking action against a pharmacy for a violation of this requirement if specified conditions apply, including if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. The bill would require, if staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act, except that the board would be authorized to publish certain deidentified information compiled from the data in the reports in accordance with specified requirements.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician under the direct supervision and control of a pharmacist to prepare and administer influenza and COVID-19 vaccines via injection or intranasally, prepare and administer epinephrine, perform specimen collection for specified tests, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law establishes a list of specified actions that constitute unprofessional conduct.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert the efforts of a pharmacist intern or a pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements under the Pharmacy Law, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. Existing law authorizes the board to appoint an executive officer to exercise the powers and perform the duties delegated by the board. A violation of the Pharmacy Law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would require a pharmacist-in-charge or pharmacist on duty to immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The bill would require store management to take immediate and reasonable steps to address and resolve those conditions, and, if those conditions are not resolved within 24 hours, would require the pharmacist-in-charge or pharmacist on duty to ensure the board is notified. The bill would require the executive officer, upon a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, to issue a cease and desist order, as specified. The bill would make a failure to comply with the cease and desist order unprofessional conduct for a pharmacy corporation.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would require a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would prohibit the board from taking action against a pharmacy for a violation of this requirement if specified conditions apply, including if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. The bill would require, if staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act, except that the board would be authorized to publish certain deidentified information compiled from the data in the reports in accordance with specified requirements.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician under the direct supervision and control of a pharmacist to prepare and administer influenza and COVID-19 vaccines via injection or intranasally, prepare and administer epinephrine, perform specimen collection for specified tests, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law establishes a list of specified actions that constitute unprofessional conduct.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert the efforts of a pharmacist intern or a pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements under the Pharmacy Law, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. Existing law authorizes the board to appoint an executive officer to exercise the powers and perform the duties delegated by the board. A violation of the Pharmacy Law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would require a pharmacist-in-charge or pharmacist on duty to immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The bill would require store management to take immediate and reasonable steps to address and resolve those conditions, and, if those conditions are not resolved within 24 hours, would require the pharmacist-in-charge or pharmacist on duty to ensure the board is notified. The bill would require the executive officer, upon a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, to issue a cease and desist order, as specified. The bill would make a failure to comply with the cease and desist order unprofessional conduct for a pharmacy corporation.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would require a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would prohibit the board from taking action against a pharmacy for a violation of this requirement if specified conditions apply or apply, including if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. The bill would require, if staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act, except that the board would be authorized to publish certain deidentified information compiled from the data in the reports. Under the bill, a report alone would not be subject to enforcement unless the board receives other information regarding the medication error. reports in accordance with specified requirements.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician under the direct supervision and control of a pharmacist to prepare and administer influenza and COVID-19 vaccines via injection or intranasally, prepare and administer epinephrine, perform specimen collection for specified tests, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law establishes a list of specified actions that constitute unprofessional conduct.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert the efforts of a pharmacist intern or a pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements under the Pharmacy Law, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. Existing law authorizes the board to appoint an executive officer to exercise the powers and perform the duties delegated by the board. A violation of the Pharmacy Law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would require a pharmacist-in-charge or pharmacist on duty to immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The bill would require store management to take immediate and reasonable steps to address and resolve those conditions, and, if those conditions are not resolved within 24 hours, would require the pharmacist-in-charge or pharmacist on duty to ensure the board is notified. The bill would require the executive officer, upon a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, to issue a cease and desist order, as specified. The bill would make a failure to comply with the cease and desist order unprofessional conduct for a pharmacy corporation.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would require a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would prohibit the board from taking action against a pharmacy for a violation of this requirement if specified conditions apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. The bill would require, if staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. Act, except that the board would be authorized to publish deidentified information compiled from the data in the reports. Under the bill, a report alone would not be subject to enforcement unless the board receives other information regarding the medication error.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician under the direct supervision and control of a pharmacist to administer influenza and COVID-19 vaccines via injection or intranasally, administer epinephrine, perform specimen collection for specified tests, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law establishes a list of specified actions that constitute unprofessional conduct.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert the efforts of a pharmacist intern or a pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements under the Pharmacy Law, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. Existing law authorizes the board to appoint an executive officer to exercise the powers and perform the duties delegated by the board. A violation of the Pharmacy Law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would require a pharmacist-in-charge or pharmacist on duty to immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The bill would require store management to take immediate and reasonable steps to address and resolve those conditions, and, if those conditions are not resolved within 24 hours, would require the pharmacist-in-charge or pharmacist on duty to ensure the board is notified. The bill would require the executive officer, upon a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, to issue a cease and desist order, as specified. The bill would make a failure to comply with the cease and desist order unprofessional conduct for a pharmacy corporation.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would authorize the pharmacist on duty to close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under existing law in a safe manner without fear of retaliation. The bill would require a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would prohibit the board from taking action against a pharmacy for a violation of this clerk or pharmacy technician staffing requirement if specified conditions apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. The bill would require, if staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. Under the bill, a report alone would not be subject to enforcement unless the board receives other information regarding the medication error.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician under the direct supervision and control of a pharmacist to administer influenza and COVID-19 vaccines via injection or intranasally, administer epinephrine, perform specimen collection for specified tests, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law provides that unprofessional conduct includes, but is not limited to, any of the specified actions. establishes a list of specified actions that constitute unprofessional conduct.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and a pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements under the Pharmacy Law, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. Existing law authorizes the board to appoint an executive officer to exercise the powers and perform the duties delegated by the board. A violation of existing law the Pharmacy Law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would authorize require a pharmacist-in-charge to close a pharmacy under or pharmacist on duty to immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The bill would require the pharmacist-in-charge to reopen, or authorize reopening, the pharmacy immediately upon the abatement of the condition or conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, if the abatement has occurred during regular pharmacy business hours. store management to take immediate and reasonable steps to address and resolve those conditions, and, if those conditions are not resolved within 24 hours, would require the pharmacist-in-charge or pharmacist on duty to ensure the board is notified. The bill would require the executive officer, upon a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, to issue a cease and desist order, as specified. The bill would make a failure to comply with the cease and desist order unprofessional conduct for a pharmacy corporation.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would authorize the pharmacist on duty to close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under existing law in a safe manner without fear of retaliation. The bill would require a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would prohibit the board from taking action against a pharmacy for a violation of this clerk or pharmacy technician staffing requirement if specified conditions apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. The bill would require, if staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. Under the bill, a report alone would not be subject to enforcement unless the board receives other information regarding the medication error.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician under the direct supervision and control of a pharmacist to administer influenza and COVID-19 vaccines, vaccines via injection or intranasally, administer epinephrine, perform specimen collection for specified tests, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law provides that unprofessional conduct includes, but is not limited to, any of the specified actions.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements under the Pharmacy Law, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. A violation of existing law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would authorize a pharmacist-in-charge, or, if not available, the pharmacist on duty, to close a pharmacy under conditions that, based on the pharmacist-in-charges professional judgment, present an immediate risk to the health and safety of patients, personnel, or pharmacy staff. The bill would require the pharmacist-in-charge or pharmacist on duty to reopen the pharmacy as soon as reasonably possible upon the abatement of the condition or conditions that presented an immediate risk to the health and safety of patients, personnel, or pharmacy staff. pharmacist-in-charge to close a pharmacy under conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The bill would require the pharmacist-in-charge to reopen, or authorize reopening, the pharmacy immediately upon the abatement of the condition or conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, if the abatement has occurred during regular pharmacy business hours.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would authorize the pharmacist on duty to close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under existing law in a safe manner without fear of retaliation. The bill would require a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would prohibit the board from taking action against a pharmacy for a violation of this clerk or pharmacy technician staffing requirement if specified conditions apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. The bill would require, if staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message. The bill would define community pharmacy for these purposes.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. Under the bill, a report alone would not be subject to enforcement unless the board receives other information regarding the medication error.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician to administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for specified tests, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law provides that unprofessional conduct includes, but is not limited to, any of the specified actions.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements under the Pharmacy Law, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. A violation of existing law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would authorize a pharmacist-in-charge, or, if not available, the pharmacist on duty, to close a pharmacy if workplace hazards, as specified, may create an unsafe environment for personnel under conditions that, based on the pharmacist-in-charges professional judgment, present an immediate risk to the health and safety of patients, personnel, or pharmacy staff. The bill would require the pharmacist-in-charge or pharmacist on duty to reopen the pharmacy as soon as reasonably possible upon the abatement of the condition or conditions that presented an immediate risk to the health and safety of patients, personnel, or pharmacy staff.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would authorize the pharmacist on duty to close a community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under existing law in a safe manner without fear of retaliation. The bill would require a community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would prohibit the board from taking action against a pharmacy for a violation of this clerk or pharmacy technician staffing requirement if specified conditions apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. The bill would require, if staffing of pharmacist hours does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message. The bill would define community pharmacy for these purposes.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. Under the bill, a report alone would not be subject to enforcement unless the board receives other information regarding the medication error.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician to administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for specified tests, receive verbal prescriptions, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law provides that unprofessional conduct includes, but is not limited to, any of the specified actions.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements, requirements under the Pharmacy Law, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law, the Pharmacy Law, provides for the licensure and regulation of pharmacists, pharmacy technicians, and pharmacies by the California State Board of Pharmacy, which is within the Department of Consumer Affairs. A violation of existing law is a crime.
(1) Existing law requires every pharmacy to designate a pharmacist-in-charge who is responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would authorize a pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. The bill would authorize a pharmacist on duty, if the pharmacist-in-charge is not available, to adjust staffing according to workload if needed. The bill would authorize a pharmacist-in-charge, or, if not available, the pharmacist on duty, to close a pharmacy if workplace hazards, as specified, may create an unsafe environment for personnel or pharmacy staff.
(2) Existing law, with specified exceptions, prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
This bill would authorize the pharmacist on duty to close a community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services in a safe manner without fear of retaliation. The bill would require a community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would require, if staffing of pharmacist hours does not overlap sufficiently, that scheduled closures for lunch time for all pharmacy staff be established and publicly posted and included on the outgoing telephone message. The bill would define community pharmacy for these purposes.
The bill would require a licensed community pharmacy, as defined, to report all medication errors to an entity approved by the board and to maintain records, as prescribed. The bill would deem these reports confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. Under the bill, a report alone would not be subject to enforcement unless the board receives other information regarding the medication error.
(3)Existing law authorizes a pharmacy technician to perform prescribed nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist who is responsible for the duties performed under their supervision by a technician. Existing law prohibits a pharmacy with only one pharmacist from having more than one pharmacy technician performing these tasks.
This bill would additionally authorize a pharmacy technician to administer vaccines, administer epinephrine, perform specimen collection for specified tests, receive verbal prescriptions, receive prescription transfers, and accept clarification on prescriptions under prescribed conditions. The bill would prohibit a pharmacy with only one pharmacist from having more than one pharmacy technician performing these additionally authorized tasks and specify that if a pharmacy technician is performing these additionally authorized tasks, a second pharmacy technician is required to be assisting a pharmacist with performing the nondiscretionary tasks currently authorized under existing law.
(4)Existing law establishes specific provisions for the licensure of clinics, including requiring a clinic that makes an application for a license to show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. Existing law requires a consulting pharmacist be retained to approve the clinics policies and procedures in conjunction with the professional director and the administrator and to visit the clinic regularly and at least quarterly. Existing law requires the consulting pharmacist to certify in writing quarterly that the clinic is, or is not, operating in compliance with existing law governing clinics.
This bill would require a consulting pharmacist, before July 1 of every odd-numbered year, to complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education, as specified, including a requirement that the professional director of the clinic and consulting pharmacist make a prescribed certification signed under penalty of perjury, kept on file in the clinic for 3 years, and made available to the board or its designee, upon request. The bill would require, as part of the renewal process for a clinic license, that the consulting pharmacist certify compliance with the quarterly inspections and provide the most recent self-assessment form.
By expanding the crime of perjury, this bill would impose a state-mandated local program.
(5)Existing law requires the board to take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Existing law provides that unprofessional conduct includes, but is not limited to, any of the specified actions.
This bill would expand the list of specified actions that constitute unprofessional conduct to include actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner; actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations; or establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
(6)Existing law authorizes the board to issue a cease and desist order for operating any facility under existing law that requires licensure or for practicing any activity under existing law that requires licensure without obtaining that licensure.
This bill would authorize the board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
(7)By imposing new requirements, the violation of which would be a crime, this bill would impose as state-mandated local program.
(8)Existing constitutional provisions require that a statute that limits the right of access to the meetings of public bodies or the writings of public officials and agencies be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest.
This bill would make legislative findings to that effect.
(9)The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)(1)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
(2)The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed. This paragraph does not apply to facilities of the Department of Corrections and Rehabilitation.
(d)(1)The pharmacist-in-charge or pharmacist on duty shall immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. Store management shall take immediate and reasonable steps to address and resolve the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. If the conditions are not resolved within 24 hours, the pharmacist-in-charge or pharmacist on duty shall ensure the board is timely notified.
(2)Nothing in this subdivision shall be construed as presenting, limiting, or restraining a pharmacist-in-charge, pharmacy technician, or member of the public from communication with the board, including filing a complaint.
(3)The conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, but are not limited to, any of the following:
(A)Workplace safety and health hazards that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(B)Sustained temperatures that could impact ambient temperature drug stability according to manufacturer data on acceptable drug storage conditions.
(C)Vermin infestation that poses a risk to the safety or efficacy of medicine.
(4)If, after receipt of a notice described in paragraph (1) and an evaluation and assessment of the relevant evidence, the executive officer has a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, the executive officer may, in conformance with the processes set forth in subdivisions (b) and (c) of Section 4127.3, issue an order to the pharmacy to immediately cease and desist those pharmacy operations that are affected by the conditions at issue. The cease and desist order shall remain in effect until either the executive officer determines the conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff have been abated or for no more than 30 days, whichever is earlier. Evidence of corrective actions taken shall be submitted by the pharmacy to correct the conditions at issue. Failure to comply with a cease and desist order issued pursuant to this section shall be unprofessional conduct pursuant to Section 4156.
(5)Nothing in this paragraph shall prevent the owner of the licensed premises from closing a pharmacy to mitigate against a perceived immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(6)Facilities of the Department of Corrections and Rehabilitation shall be exempt from this subdivision.
(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)Except as specified in subdivision (e), a community pharmacy licensed pursuant to this article shall report, either directly or through a designated third party, including a component patient safety organization as defined in Section 3.20 of Title 42 of the Code of Federal Regulations, all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code), except that the board may publish deidentified case summary information compiled from the data in the reports so long as deidentification is done in accordance with the requirements set forth in Section 164.514(b)(2) of Title 45 of the Code of Federal Regulations, and includes omitting the name of the reporting pharmacy. The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to investigation, discipline, or other enforcement action by the board based solely on a report received pursuant to this section. However, if the board receives other information regarding the medication error independent of the medication error report, that information may serve as basis for discipline or other enforcement by the board.
(b)Any entity approved by the board shall have experience with the analysis of medication errors that occur in the outpatient setting.
(c)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient, but does not include facilities of the Department of Corrections and Rehabilitation.
(d)For purposes of this section, medication error includes any variation from a prescription drug order not authorized by the prescriber, including, but not limited to, errors involving the wrong drug, the wrong dose, the wrong patient, the wrong directions, the wrong preparation, or the wrong route of administration. A medication error does not include any variation that is corrected prior to dispensing to the patient or patients agent or any variation allowed by law.
(e)An outpatient hospital pharmacy shall not be required to report a medication error that meets the requirements of an adverse event, as specified in subdivision (a), that has been reported to the State Department of Public Health pursuant to Section 1279.1 of the Health and Safety Code. The State Department of Public Health may share a report with the California State Board of Pharmacy.
SEC. 3.Section 4113.6 is added to the Business and Professions Code, to read:4113.6.(a)A chain community pharmacy subject to Section 4113.5 shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The board shall not take action against a pharmacy for a violation of this subdivision if any of the following conditions apply:
(1)The pharmacist on duty waives the requirement in writing during specified hours based on workload need.
(2)The pharmacy is open beyond normal business hours, which is before 8:00 am and after 7:00 pm. During the hours before 8:00 am and after 7:00 pm, the requirement shall not apply.
(3)The pharmacys prescription volume per day on average is less than 75 prescriptions per day based on the average daily prescription volume for the past calendar year. However, if the pharmacist is also expected to provide additional pharmacy services such as immunizations, tests classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a), or any other ancillary services provided by law, this paragraph does not apply.
(b)Where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may, under the direct supervision and control of a pharmacist, prepare and administer influenza and COVID-19 vaccines via injection or intranasally, prepare and administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(B)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(C)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(D)The pharmacy technician is certified in basic life support.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(c)This section does not authorize the performance of any tasks specified in subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist-in-charge in writing of their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(h)Notwithstanding subdivisions (a) to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (g).
(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist-in-charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in their capacity as medical director or a dentist or podiatrist acting in their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to a person with substance use disorder.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in Section 256b(a)(4) of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
(w)Actions or conduct that would subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
(x)Actions or conduct that would subvert the efforts of a pharmacist intern or a pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policymakers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)(1)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
(2)The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed. This paragraph does not apply to facilities of the Department of Corrections and Rehabilitation.
(d)(1)The pharmacist-in-charge or pharmacist on duty shall immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. Store management shall take immediate and reasonable steps to address and resolve the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. If the conditions are not resolved within 24 hours, the pharmacist-in-charge or pharmacist on duty shall ensure the board is timely notified.
(2)Nothing in this subdivision shall be construed as presenting, limiting, or restraining a pharmacist-in-charge, pharmacy technician, or member of the public from communication with the board, including filing a complaint.
(3)The conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, but are not limited to, any of the following:
(A)Workplace safety and health hazards that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(B)Sustained temperatures that could impact ambient temperature drug stability according to manufacturer data on acceptable drug storage conditions.
(C)Vermin infestation that poses a risk to the safety or efficacy of medicine.
(4)If, after receipt of a notice described in paragraph (1) and an evaluation and assessment of the relevant evidence, the executive officer has a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, the executive officer may, in conformance with the processes set forth in subdivisions (b) and (c) of Section 4127.3, issue an order to the pharmacy to immediately cease and desist those pharmacy operations that are affected by the conditions at issue. The cease and desist order shall remain in effect until either the executive officer determines the conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff have been abated or for no more than 30 days, whichever is earlier. Evidence of corrective actions taken shall be submitted by the pharmacy to correct the conditions at issue. Failure to comply with a cease and desist order issued pursuant to this section shall be unprofessional conduct pursuant to Section 4156.
(5)Nothing in this paragraph shall prevent the owner of the licensed premises from closing a pharmacy to mitigate against a perceived immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(6)Facilities of the Department of Corrections and Rehabilitation shall be exempt from this subdivision.
(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)Except as specified in subdivision (e), a community pharmacy licensed pursuant to this article shall report, either directly or through a designated third party, including a component patient safety organization as defined in Section 3.20 of Title 42 of the Code of Federal Regulations, all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code), except that the board may publish deidentified case summary information compiled from the data in the reports so long as deidentification is done in accordance with the requirements set forth in Section 164.514(b)(2) of Title 45 of the Code of Federal Regulations, and includes omitting the name of the reporting pharmacy. The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to investigation, discipline, or other enforcement action by the board based solely on a report received pursuant to this section. However, if the board receives other information regarding the medication error independent of the medication error report, that information may serve as basis for discipline or other enforcement by the board.
(b)Any entity approved by the board shall have experience with the analysis of medication errors that occur in the outpatient setting.
(c)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient, but does not include facilities of the Department of Corrections and Rehabilitation.
(d)For purposes of this section, medication error includes any variation from a prescription drug order not authorized by the prescriber, including, but not limited to, errors involving the wrong drug, the wrong dose, the wrong patient, the wrong directions, the wrong preparation, or the wrong route of administration. A medication error does not include any variation that is corrected prior to dispensing to the patient or patients agent or any variation allowed by law.
(e)An outpatient hospital pharmacy shall not be required to report a medication error that meets the requirements of an adverse event, as specified in subdivision (a), that has been reported to the State Department of Public Health pursuant to Section 1279.1 of the Health and Safety Code. The State Department of Public Health may share a report with the California State Board of Pharmacy.
SEC. 3.Section 4113.6 is added to the Business and Professions Code, to read:4113.6.(a)A chain community pharmacy subject to Section 4113.5 shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The board shall not take action against a pharmacy for a violation of this subdivision if any of the following conditions apply:
(1)The pharmacist on duty waives the requirement in writing during specified hours based on workload need.
(2)The pharmacy is open beyond normal business hours, which is before 8:00 am and after 7:00 pm. During the hours before 8:00 am and after 7:00 pm, the requirement shall not apply.
(3)The pharmacys prescription volume per day on average is less than 75 prescriptions per day based on the average daily prescription volume for the past calendar year. However, if the pharmacist is also expected to provide additional pharmacy services such as immunizations, tests classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a), or any other ancillary services provided by law, this paragraph does not apply.
(b)Where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may, under the direct supervision and control of a pharmacist, prepare and administer influenza and COVID-19 vaccines via injection or intranasally, prepare and administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(B)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(C)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(D)The pharmacy technician is certified in basic life support.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(c)This section does not authorize the performance of any tasks specified in subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist-in-charge in writing of their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(h)Notwithstanding subdivisions (a) to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (g).
(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist-in-charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in their capacity as medical director or a dentist or podiatrist acting in their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to a person with substance use disorder.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in Section 256b(a)(4) of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
(w)Actions or conduct that would subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
(x)Actions or conduct that would subvert the efforts of a pharmacist intern or a pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policymakers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)(1)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. The
(2)The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed. This paragraph does not apply to facilities of the Department of Corrections and Rehabilitation.
(d)(1)The pharmacist-in-charge or pharmacist on duty shall immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. Store management shall take immediate and reasonable steps to address and resolve the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. If the conditions are not resolved within 24 hours, the pharmacist-in-charge or pharmacist on duty shall ensure the board is timely notified.
(2)Nothing in this subdivision shall be construed as presenting, limiting, or restraining a pharmacist-in-charge, pharmacy technician, or member of the public from communication with the board, including filing a complaint.
(3)The conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, but are not limited to, any of the following:
(A)Workplace safety and health hazards that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(B)Sustained temperatures that could impact ambient temperature drug stability according to manufacturer data on acceptable drug storage conditions.
(C)Vermin infestation that poses a risk to the safety or efficacy of medicine.
(4)If, after receipt of a notice described in paragraph (1) and an evaluation and assessment of the relevant evidence, the executive officer has a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, the executive officer may, in conformance with the processes set forth in subdivisions (b) and (c) of Section 4127.3, issue an order to the pharmacy to immediately cease and desist those pharmacy operations that are affected by the conditions at issue. The cease and desist order shall remain in effect until either the executive officer determines the conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff have been abated or for no more than 30 days, whichever is earlier. Evidence of corrective actions taken shall be submitted by the pharmacy to correct the conditions at issue. Failure to comply with a cease and desist order issued pursuant to this section shall be unprofessional conduct pursuant to Section 4156.
(5)Nothing in this paragraph shall prevent a licensee the owner of the licensed premises from closing a pharmacy to mitigate against a perceived immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(6)Facilities of the Department of Corrections and Rehabilitation shall be exempt from this subdivision.
(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)A Except as specified in subdivision (e), a community pharmacy licensed pursuant to this article shall report report, either directly or through a designated third party, including a component patient safety organization as defined in Section 3.20 of Title 42 of the Code of Federal Regulations, all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code), except that the board may publish deidentified case summary information compiled from the data in the reports. reports so long as deidentification is done in accordance with the requirements set forth in Section 164.514(b)(2) of Title 45 of the Code of Federal Regulations, and includes omitting the name of the reporting pharmacy. The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to discipline investigation, discipline, or other enforcement action by the board based solely on the report. a report received pursuant to this section. However, if the board receives other information regarding the medication error, error independent of the medication error report, that information may serve as basis for discipline or other enforcement by the board.
(b)Any entity approved by the board shall have experience with the analysis of medication errors that occur in the outpatient setting.
(b)(c)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient. outpatient, but does not include facilities of the Department of Corrections and Rehabilitation.
(d)For purposes of this section, medication error includes any variation from a prescription drug order not authorized by the prescriber, including, but not limited to, errors involving the wrong drug, the wrong dose, the wrong patient, the wrong directions, the wrong preparation, or the wrong route of administration. A medication error does not include any variation that is corrected prior to dispensing to the patient or patients agent or any variation allowed by law.
(e)An outpatient hospital pharmacy shall not be required to report a medication error that meets the requirements of an adverse event, as specified in subdivision (a), that has been reported to the State Department of Public Health pursuant to Section 1279.1 of the Health and Safety Code. The State Department of Public Health may share a report with the California State Board of Pharmacy.
SEC. 3.Section 4113.6 is added to the Business and Professions Code, to read:4113.6.(a)A chain community pharmacy subject to Section 4113.5 shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The board shall not take action against a pharmacy for a violation of this subdivision if the conditions of subdivision (d) of Section 4113.5 apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. any of the following conditions apply:
(1)The pharmacist on duty waives the requirement in writing during specified hours based on workload need.
(2)The pharmacy is open beyond normal business hours, which is before 8:00 am and after 7:00 pm. During the hours before 8:00 am and after 7:00 pm, the requirement shall not apply.
(3)The pharmacys prescription volume per day on average is less than 75 prescriptions per day based on the average daily prescription volume for the past calendar year. However, if the pharmacist is also expected to provide additional pharmacy services such as immunizations, tests classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a), or any other ancillary services provided by law, this paragraph does not apply.
(b)Where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may, under the direct supervision and control of a pharmacist, prepare and administer influenza and COVID-19 vaccines via injection or intranasally, prepare and administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(B)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(C)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(D)The pharmacy technician is certified in basic life support.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(c)This section does not authorize the performance of any tasks specified in subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist-in-charge in writing of their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(h)Notwithstanding subdivisions (a) to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (g).
(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist-in-charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in their capacity as medical director or a dentist or podiatrist acting in their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to an addict. a person with substance use disorder.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in Section 256b(a)(4) of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
(w)Actions or conduct that would subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
(x)Actions or conduct that would subvert the efforts of a pharmacist intern or a pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements. This subdivision does not apply to facilities of the Department of Corrections and Rehabilitation.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policymakers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed.
(d)(1)The pharmacist-in-charge or pharmacist on duty shall immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. Store management shall take immediate and reasonable steps to address and resolve the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. If the conditions are not resolved within 24 hours, the pharmacist-in-charge or pharmacist on duty shall ensure the board is timely notified.
(2)Nothing in this subdivision shall be construed as presenting, limiting, or restraining a pharmacist-in-charge, pharmacy technician, or member of the public from communication with the board, including filing a complaint.
(3)The conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, but are not limited to, any of the following:
(A)Workplace safety and health hazards that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(B)Sustained temperatures that could impact ambient temperature drug stability according to manufacturer data on acceptable drug storage conditions.
(C)Vermin infestation that poses a risk to the safety or efficacy of medicine.
(4)If, after receipt of a notice described in paragraph (1) and an evaluation and assessment of the relevant evidence, the executive officer has a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, the executive officer may, in conformance with the processes set forth in subdivisions (b) and (c) of Section 4127.3, issue an order to the pharmacy to immediately cease and desist those pharmacy operations that are affected by the conditions at issue. The cease and desist order shall remain in effect until either the executive officer determines the conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff have been abated or for no more than 30 days, whichever is earlier. Evidence of corrective actions taken shall be submitted by the pharmacy to correct the conditions at issue. Failure to comply with a cease and desist order issued pursuant to this section shall be unprofessional conduct pursuant to Section 4156.
(5)Nothing in this paragraph shall prevent a licensee from closing a pharmacy to mitigate against a perceived immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)A community pharmacy licensed pursuant to this article shall report all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code). Code), except that the board may publish deidentified information compiled from the data in the reports. The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to discipline or other enforcement action by the board based solely on the report. However, if the board receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the board.
(b)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.
SEC. 3.Section 4113.6 is added to the Business and Professions Code, to read:4113.6.(a)A chain community pharmacy shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The board shall not take action against a pharmacy for a violation of this subdivision if the conditions of subdivision (d) of Section 4113.5 apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs.
(b)Where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may, under the direct supervision and control of a pharmacist, administer influenza and COVID-19 vaccines via injection or intranasally, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(B)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(C)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(D)The pharmacy technician is certified in basic life support.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(c)This section does not authorize the performance of any tasks specified in subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist-in-charge in writing of their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(h)Notwithstanding subdivisions (a) to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (g).
(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist-in-charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in their capacity as medical director or a dentist or podiatrist acting in their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to an addict.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in Section 256b(a)(4) of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
(w)Actions or conduct that would subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
(x)Actions or conduct that would subvert the efforts of a pharmacist intern or a pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policymakers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed.
(d)(1)The pharmacist-in-charge or pharmacist on duty shall immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. Store management shall take immediate and reasonable steps to address and resolve the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. If the conditions are not resolved within 24 hours, the pharmacist-in-charge or pharmacist on duty shall ensure the board is timely notified.
(2)Nothing in this subdivision shall be construed as presenting, limiting, or restraining a pharmacist-in-charge, pharmacy technician, or member of the public from communication with the board, including filing a complaint.
(3)The conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, but are not limited to, any of the following:
(A)Workplace safety and health hazards, including those contained in Division 5 (commencing with Section 6300) of the Labor Code. hazards that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(B)Sustained temperatures that could impact ambient temperature drug stability according to manufacturer data on acceptable drug storage conditions.
(C)Vermin infestation that poses a risk to the safety or efficacy of medicine.
(4)If, after receipt of a notice described in paragraph (1) and an evaluation and assessment of the relevant evidence, the executive officer has a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, the executive officer may, in conformance with the processes set forth in subdivisions (b) and (c) of Section 4127.3, issue an order to the pharmacy to immediately cease and desist those pharmacy operations that are affected by the conditions at issue. The cease and desist order shall remain in effect until either the executive officer determines the conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff have been abated or for no more than 30 days, whichever is earlier. Evidence of corrective actions taken shall be submitted by the pharmacy to correct the conditions at issue. Failure to comply with a cease and desist order issued pursuant to this section shall be unprofessional conduct pursuant to Section 4156.
(5)Nothing in this paragraph shall prevent a permitholder licensee from closing a pharmacy to mitigate against a perceived immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)A community pharmacy licensed pursuant to this article shall report all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code). The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to discipline or other enforcement action by the board based solely on the report. However, if the board receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the board.
(b)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.
SEC. 3.Section 4113.5 of the Business and Professions Code is amended to read:4113.5.(a)A community pharmacy shall not require a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.(b)This section shall not apply to any of the following:(1)A hospital pharmacy, as defined in Section 4029 or 4056.(2)A pharmacy located in a hospital facility, including, but not limited to, a building where outpatient services are provided in accordance with the hospitals license.(3)A pharmacy owned or operated by a federal, state, local, or tribal government entity, including, but not limited to, a correctional pharmacy, a University of California pharmacy, or a pharmacy operated by the State Department of State Hospitals.(4)A pharmacy owned by a person or persons who, collectively, control the majority of the beneficial interest in no more than four pharmacies in California.(5)A pharmacy entirely owned and operated by a health care service plan that exclusively contracts with no more than two medical groups in the state to provide, or arrange for the provision of, professional medical services to the enrollees of the plan.(6)A pharmacy that permits patients to receive medications at a drive-through window when both of the following conditions are met:(A)A pharmacist is working during the times when patients may receive medication only at the drive-through window.(B)The pharmacists employer does not require the pharmacist to retrieve items for sale to patients if the items are located outside the pharmacy. These items include, but are not limited to, items for which a prescription is not required.(7)Any other pharmacy from which controlled substances, dangerous drugs, or dangerous devices are not furnished, sold, or dispensed at retail.(c)A violation of subdivision (a) is not subject to subdivision (a) of Section 4321.(d)The board shall not take action against a pharmacy for a violation of this section if both of the following apply:(1)Another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, including, but not limited to, illness, injury, family emergency, or the employees termination or resignation.(2)The pharmacy takes all reasonable action to make another employee available to assist the pharmacist.(e)The pharmacist on duty may close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under this chapter in a safe manner without fear of retaliation.(f)(1)A chain community pharmacy shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The board shall not take action against a pharmacy for a violation of this paragraph if the conditions of subdivision (d) apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs.(2)Where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message. (g)This section shall not be construed to permit an employee who is not licensed under this chapter to engage in any act for which a license is required under this chapter.SEC. 3.Section 4113.6 is added to the Business and Professions Code, to read:4113.6.(a)A chain community pharmacy shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The board shall not take action against a pharmacy for a violation of this subdivision if the conditions of subdivision (d) of Section 4113.5 apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs.
(b)Where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may, under the direct supervision and control of a pharmacist, administer influenza and COVID-19 vaccines via injection or intranasally, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacist-in-charge of the pharmacy at which the tasks are being performed has deemed the pharmacy technician competent to perform such tasks and documented such determination in writing. Documentation shall be maintained in the pharmacy. (B)(A)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(C)(B)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(D)(C)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(E)(D)The pharmacy technician is certified in basic life support.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(c)This section does not authorize the performance of any tasks specified in subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist-in-charge in writing of their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(h)Notwithstanding subdivisions (a) to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (g).
(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist-in-charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in their capacity as medical director or a dentist or podiatrist acting in their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to an addict.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in Section 256b(a)(4) of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
(w)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
(x)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and a pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policymakers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed.
(d)(1)The pharmacist-in-charge may close a pharmacy under conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The pharmacist-in-charge shall reopen, or authorize reopening, the pharmacy immediately upon the abatement of the condition or conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, if the abatement has occurred during regular pharmacy business hours. The or pharmacist on duty shall immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. Store management shall take immediate and reasonable steps to address and resolve the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. If the conditions are not resolved within 24 hours, the pharmacist-in-charge or pharmacist on duty shall ensure the board is timely notified.
(2)Nothing in this subdivision shall be construed as presenting, limiting, or restraining a pharmacist-in-charge, pharmacy technician, or member of the public from communication with the board, including filing a complaint.
(3)The conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, but are not limited to, any of the following:
(A)Workplace safety and health hazards, including those contained in Division 5 (commencing with Section 6300) of the Labor Code.
(B)Temperatures that deviate from appropriate drug storage conditions.(B)Sustained temperatures that could impact ambient temperature drug stability according to manufacturer data on acceptable drug storage conditions.
(C)Vermin infestation that poses a risk to the safety or efficacy of medicine.
(2)Nothing in this subdivision shall be interpreted to prohibit a pharmacist-in-charge from continuing to provide patient care services that can be performed without posing an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, including allowing for the transfer of prescriptions to another pharmacy as may be necessary to ensure continuity of patient care.(4)If, after receipt of a notice described in paragraph (1) and an evaluation and assessment of the relevant evidence, the executive officer has a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, the executive officer may, in conformance with the processes set forth in subdivisions (b) and (c) of Section 4127.3, issue an order to the pharmacy to immediately cease and desist those pharmacy operations that are affected by the conditions at issue. The cease and desist order shall remain in effect until either the executive officer determines the conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff have been abated or for no more than 30 days, whichever is earlier. Evidence of corrective actions taken shall be submitted by the pharmacy to correct the conditions at issue. Failure to comply with a cease and desist order issued pursuant to this section shall be unprofessional conduct pursuant to Section 4156.
(5)Nothing in this paragraph shall prevent a permitholder from closing a pharmacy to mitigate against a perceived immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)A community pharmacy licensed pursuant to this article shall report all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code). The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to discipline or other enforcement action by the board based solely on the report. However, if the board receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the board.
(b)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.
SEC. 3.Section 4113.5 of the Business and Professions Code is amended to read:4113.5.(a)A community pharmacy shall not require a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
(b)This section shall not apply to any of the following:
(1)A hospital pharmacy, as defined in Section 4029 or 4056.
(2)A pharmacy located in a hospital facility, including, but not limited to, a building where outpatient services are provided in accordance with the hospitals license.
(3)A pharmacy owned or operated by a federal, state, local, or tribal government entity, including, but not limited to, a correctional pharmacy, a University of California pharmacy, or a pharmacy operated by the State Department of State Hospitals.
(4)A pharmacy owned by a person or persons who, collectively, control the majority of the beneficial interest in no more than four pharmacies in California.
(5)A pharmacy entirely owned and operated by a health care service plan that exclusively contracts with no more than two medical groups in the state to provide, or arrange for the provision of, professional medical services to the enrollees of the plan.
(6)A pharmacy that permits patients to receive medications at a drive-through window when both of the following conditions are met:
(A)A pharmacist is working during the times when patients may receive medication only at the drive-through window.
(B)The pharmacists employer does not require the pharmacist to retrieve items for sale to patients if the items are located outside the pharmacy. These items include, but are not limited to, items for which a prescription is not required.
(7)Any other pharmacy from which controlled substances, dangerous drugs, or dangerous devices are not furnished, sold, or dispensed at retail.
(c)A violation of subdivision (a) is not subject to subdivision (a) of Section 4321.
(d)The board shall not take action against a pharmacy for a violation of this section if both of the following apply:
(1)Another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, including, but not limited to, illness, injury, family emergency, or the employees termination or resignation.
(2)The pharmacy takes all reasonable action to make another employee available to assist the pharmacist.
(e)The pharmacist on duty may close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under this chapter in a safe manner without fear of retaliation.
(f)(1)A chain community pharmacy shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The board shall not take action against a pharmacy for a violation of this paragraph if the conditions of subdivision (d) apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs.
(2)Where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
(g)This section shall not be construed to permit an employee who is not licensed under this chapter to engage in any act for which a license is required under this chapter.
SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may may, under the direct supervision and control of a pharmacist, administer influenza and COVID-19 vaccines, vaccines via injection or intranasally, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacist-in-charge of the pharmacy at which the tasks are being performed has deemed the pharmacy technician competent to perform such tasks and documented such determination in writing. Documentation shall be maintained in the pharmacy.
(B)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(C)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(D)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(E)The pharmacy technician is certified in basic life support.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(c)This section does not authorize the performance of any tasks specified in subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist-in-charge in writing of their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(h)Notwithstanding subdivisions (a) to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (g).
(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist-in-charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in their capacity as medical director or a dentist or podiatrist acting in their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to an addict.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in paragraph (4) of subsection (a) of Section 256b 256b(a)(4) of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
(w)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
(x)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policymakers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed.
(d)(1)The pharmacist-in-charge may close a pharmacy under conditions that, based on the pharmacist-in-charges professional judgment, that present an immediate risk to the health and safety of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. If the pharmacist-in-charge is not available, the pharmacist on duty may close the pharmacy for the reasons described in this subdivision. The pharmacist-in-charge or pharmacist on duty shall reopen reopen, or authorize reopening, the pharmacy as soon as reasonably possible immediately upon the abatement of the condition or conditions that presented an immediate risk to the health and safety of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. staff, if the abatement has occurred during regular pharmacy business hours. The conditions described by this subdivision that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, but are not limited to, any of the following:
(1)(A)Workplace safety and health hazards, including those contained in Division 5 (commencing with Section 6300) of the Labor Code.
(2)(B)Temperatures that deviate from appropriate drug storage conditions.
(3)Other conditions that present an immediate risk to the health and safety of patients, personnel, or pharmacy staff.(C)Vermin infestation that poses a risk to the safety or efficacy of medicine.
(2)Nothing in this subdivision shall be interpreted to prohibit a pharmacist-in-charge from continuing to provide patient care services that can be performed without posing an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, including allowing for the transfer of prescriptions to another pharmacy as may be necessary to ensure continuity of patient care.
(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)A community pharmacy licensed pursuant to this article shall report all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code). The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to discipline or other enforcement action by the board based solely on the report. However, if the board receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the board.
(b)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.
SEC. 3.Section 4113.5 of the Business and Professions Code is amended to read:4113.5.(a)A community pharmacy shall not require a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
(b)This section shall not apply to any of the following:
(1)A hospital pharmacy, as defined in Section 4029 or 4056.
(2)A pharmacy located in a hospital facility, including, but not limited to, a building where outpatient services are provided in accordance with the hospitals license.
(3)A pharmacy owned or operated by a federal, state, local, or tribal government entity, including, but not limited to, a correctional pharmacy, a University of California pharmacy, or a pharmacy operated by the State Department of State Hospitals.
(4)A pharmacy owned by a person or persons who, collectively, control the majority of the beneficial interest in no more than four pharmacies in California.
(5)A pharmacy entirely owned and operated by a health care service plan that exclusively contracts with no more than two medical groups in the state to provide, or arrange for the provision of, professional medical services to the enrollees of the plan.
(6)A pharmacy that permits patients to receive medications at a drive-through window when both of the following conditions are met:
(A)A pharmacist is working during the times when patients may receive medication only at the drive-through window.
(B)The pharmacists employer does not require the pharmacist to retrieve items for sale to patients if the items are located outside the pharmacy. These items include, but are not limited to, items for which a prescription is not required.
(7)Any other pharmacy from which controlled substances, dangerous drugs, or dangerous devices are not furnished, sold, or dispensed at retail.
(c)A violation of subdivision (a) is not subject to subdivision (a) of Section 4321.
(d)The board shall not take action against a pharmacy for a violation of this section if both of the following apply:
(1)Another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, including, but not limited to, illness, injury, family emergency, or the employees termination or resignation.
(2)The pharmacy takes all reasonable action to make another employee available to assist the pharmacist.
(e)The pharmacist on duty may close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under this chapter in a safe manner without fear of retaliation.
(f)(1)A chain community pharmacy shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The board shall not take action against a pharmacy for a violation of this paragraph if the conditions of subdivision (d) apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs.
(2)Where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
(g)This section shall not be construed to permit an employee who is not licensed under this chapter to engage in any act for which a license is required under this chapter.
(h)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacist-in-charge of the pharmacy at which the tasks are being performed has deemed the pharmacy technician competent to perform such tasks and documented such determination in writing. Documentation shall be maintained in the pharmacy.
(B)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(C)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(D)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(c)This section does not authorize the performance of any tasks specified in subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist-in-charge in writing of their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(h)Notwithstanding subdivisions (a) to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (g).
(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist-in-charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in their capacity as medical director or a dentist or podiatrist acting in their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to an addict.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in paragraph (4) of subsection (a) of Section 256b of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
(w)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
(x)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policymakers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed.
(d)The pharmacist-in-charge may close a pharmacy if workplace hazards, such as unsanitary conditions, temperatures that deviate from appropriate drug storage conditions, or other conditions that, based on their professional judgment, may create an unsafe environment for personnel under conditions that, based on the pharmacist-in-charges professional judgment, present an immediate risk to the health and safety of patients, personnel, or pharmacy staff. If the pharmacist-in-charge is not available, the pharmacist on duty may close the pharmacy for the reasons described in this subdivision. The pharmacist-in-charge or pharmacist on duty shall reopen the pharmacy as soon as reasonably possible upon the abatement of the condition or conditions that presented an immediate risk to the health and safety of patients, personnel, or pharmacy staff. The conditions described by this subdivision may include, but are not limited to, any of the following:
(1)Workplace safety and health hazards, including those contained in Division 5 (commencing with Section 6300) of the Labor Code.
(2)Temperatures that deviate from appropriate drug storage conditions.
(3)Other conditions that present an immediate risk to the health and safety of patients, personnel, or pharmacy staff.
(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)A community pharmacy licensed pursuant to this article shall report all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code). The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to discipline or other enforcement action by the board based solely on the report. However, if the board receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the board.
(b)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.
SEC. 3.Section 4113.5 of the Business and Professions Code is amended to read:4113.5.(a)A community pharmacy shall not require a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
(b)This section shall not apply to any of the following:
(1)A hospital pharmacy, as defined in Section 4029 or 4056.
(2)A pharmacy located in a hospital facility, including, but not limited to, a building where outpatient services are provided in accordance with the hospitals license.
(3)A pharmacy owned or operated by a federal, state, local, or tribal government entity, including, but not limited to, a correctional pharmacy, a University of California pharmacy, or a pharmacy operated by the State Department of State Hospitals.
(4)A pharmacy owned by a person or persons who, collectively, control the majority of the beneficial interest in no more than four pharmacies in California.
(5)A pharmacy entirely owned and operated by a health care service plan that exclusively contracts with no more than two medical groups in the state to provide, or arrange for the provision of, professional medical services to the enrollees of the plan.
(6)A pharmacy that permits patients to receive medications at a drive-through window when both of the following conditions are met:
(A)A pharmacist is working during the times when patients may receive medication only at the drive-through window.
(B)The pharmacists employer does not require the pharmacist to retrieve items for sale to patients if the items are located outside the pharmacy. These items include, but are not limited to, items for which a prescription is not required.
(7)Any other pharmacy from which controlled substances, dangerous drugs, or dangerous devices are not furnished, sold, or dispensed at retail.
(c)A violation of subdivision (a) is not subject to subdivision (a) of Section 4321.
(d)The board shall not take action against a pharmacy for a violation of this section if both of the following apply:
(1)Another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, including, but not limited to, illness, injury, family emergency, or the employees termination or resignation.
(2)The pharmacy takes all reasonable action to make another employee available to assist the pharmacist.
(e)The pharmacist on duty may close a community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under this chapter in a safe manner without fear of retaliation.
(f)(1)A community pharmacy shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. Where The board shall not take action against a pharmacy for a violation of this paragraph if the conditions of subdivision (d) apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs.
(2)Where staffing of pharmacist hours does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
(g)This section shall not be construed to permit an employee who is not licensed under this chapter to engage in any act for which a license is required under this chapter.
(h)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.
SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive verbal prescriptions, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacist-in-charge of the pharmacy at which the tasks are being performed has deemed the pharmacy technician competent to perform such tasks and documented such determination in writing. Documentation shall be maintained in the pharmacy.
(B)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(C)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(D)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(c)This section does not authorize the performance of any tasks specified in subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist in charge pharmacist-in-charge in writing of their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(h)Notwithstanding subdivisions (a) to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (g).
(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist in charge pharmacist-in-charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in their capacity as medical director or a dentist or podiatrist acting in their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to an addict.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in paragraph (4) of subsection (a) of Section 256b of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
(w)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
(x)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policy makers policymakers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a)Every pharmacy shall designate a pharmacist-in-charge and, within 30 days thereof, shall notify the board in writing of the identity and license number of that pharmacist and the date he or she was they were designated.
(b)The proposed pharmacist-in-charge shall be subject to approval by the board. The board shall not issue or renew a pharmacy license without identification of an approved pharmacist-in-charge for the pharmacy.
(c)The pharmacist-in-charge shall be responsible for a pharmacys compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. The pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacists ability to practice competently and safely. If the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed.
(d)The pharmacist-in-charge may close a pharmacy if workplace hazards, such as unsanitary conditions, temperatures that deviate from appropriate drug storage conditions, or other conditions that, based on their professional judgment, may create an unsafe environment for personnel or pharmacy staff. If the pharmacist-in-charge is not available, the pharmacist on duty may close the pharmacy for the reasons described in this subdivision.
(d)(e)Every pharmacy shall notify the board in writing, on a form designed by the board, within 30 days of the date when a pharmacist-in-charge ceases to act as the pharmacist-in-charge, and shall on the same form propose another pharmacist to take over as the pharmacist-in-charge. The proposed replacement pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
(e)(f)If a pharmacy is unable, in the exercise of reasonable diligence, to identify within 30 days a permanent replacement pharmacist-in-charge to propose to the board on the notification form, the pharmacy may instead provide on that form the name of any pharmacist who is an employee, officer, or administrator of the pharmacy or the entity that owns the pharmacy and who is actively involved in the management of the pharmacy on a daily basis, to act as the interim pharmacist-in-charge for a period not to exceed 120 days. The pharmacy, or the entity that owns the pharmacy, shall be prepared during normal business hours to provide a representative of the board with the name of the interim pharmacist-in-charge with documentation of the active involvement of the interim pharmacist-in-charge in the daily management of the pharmacy, and with documentation of the pharmacys good faith efforts prior to naming the interim pharmacist-in-charge to obtain a permanent pharmacist-in-charge. By no later than 120 days following the identification of the interim pharmacist-in-charge, the pharmacy shall propose to the board the name of a pharmacist to serve as the permanent pharmacist-in-charge. The proposed permanent pharmacist-in-charge shall be subject to approval by the board. If disapproved, the pharmacy shall propose another replacement within 15 days of the date of disapproval, and shall continue to name proposed replacements until a pharmacist-in-charge is approved by the board.
SEC. 2.Section 4113.1 is added to the Business and Professions Code, to read:4113.1.(a)A community pharmacy licensed pursuant to this article shall report all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code). The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to discipline or other enforcement action by the board based solely on the report. However, if the board receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the board.
(b)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.
SEC. 3.Section 4113.5 of the Business and Professions Code is amended to read:4113.5.(a)A community pharmacy shall not require a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times.
(b)This section shall not apply to any of the following:
(1)A hospital pharmacy, as defined in Section 4029 or 4056.
(2)A pharmacy located in a hospital facility, including, but not limited to, a building where outpatient services are provided in accordance with the hospitals license.
(3)A pharmacy owned or operated by a federal, state, local, or tribal government entity, including, but not limited to, a correctional pharmacy, a University of California pharmacy, or a pharmacy operated by the State Department of State Hospitals.
(4)A pharmacy owned by a person or persons who, collectively, control the majority of the beneficial interest in no more than four pharmacies in California.
(5)A pharmacy entirely owned and operated by a health care service plan that exclusively contracts with no more than two medical groups in the state to provide, or arrange for the provision of, professional medical services to the enrollees of the plan.
(6)A pharmacy that permits patients to receive medications at a drive-through window when both of the following conditions are met:
(A)A pharmacist is working during the times when patients may receive medication only at the drive-through window.
(B)The pharmacists employer does not require the pharmacist to retrieve items for sale to patients if the items are located outside the pharmacy. These items include, but are not limited to, items for which a prescription is not required.
(7)Any other pharmacy from which controlled substances, dangerous drugs, or dangerous devices are not furnished, sold, or dispensed at retail.
(c)A violation of subdivision (a) is not subject to subdivision (a) of Section 4321.
(d)The board shall not take action against a pharmacy for a violation of this section if both of the following apply:
(1)Another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, including, but not limited to, illness, injury, family emergency, or the employees termination or resignation.
(2)The pharmacy takes all reasonable action to make another employee available to assist the pharmacist.
(e)The pharmacist on duty may close a community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services in a safe manner without fear of retaliation.
(f)A community pharmacy shall be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. Where staffing of pharmacist hours does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
(e)(g)This section shall not be construed to permit an employee who is not licensed under this chapter to engage in any act for which a license is required under this chapter.
(h)For purposes of this section, community pharmacy includes any pharmacy that dispenses medication to an outpatient.
SEC. 4.Section 4115 of the Business and Professions Code is amended to read:4115.(a)A pharmacy technician may perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. The pharmacist shall be responsible for the duties performed under his or her their supervision by a technician.
(b)(1)In addition to the tasks specified in subdivision (a) a pharmacy technician may administer vaccines, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive verbal prescriptions, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
(A)The pharmacist-in-charge of the pharmacy at which the tasks are being performed has deemed the pharmacy technician competent to perform such tasks and documented such determination in writing. Documentation shall be maintained in the pharmacy.
(B)The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks provided in subdivision (a).
(C)The pharmacy technician is certified pursuant to paragraph (4) of subdivision (a) of Section 4202 and maintains that certification.
(D)The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technicians injection technique.
(2)CLIA means the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a; Public Law 100-578).
(b)(c)This section does not authorize the performance of any tasks specified in subdivision (a) subdivisions (a) and (b) by a pharmacy technician without a pharmacist on duty.
(c)(d)This section does not authorize a pharmacy technician to perform any act requiring the exercise of professional judgment by a pharmacist.
(d)(e)The board shall adopt regulations to specify tasks pursuant to subdivision (a) that a pharmacy technician may perform under the supervision of a pharmacist. Any pharmacy that employs a pharmacy technician shall do so in conformity with the regulations adopted by the board.
(e)(f)A person shall not act as a pharmacy technician without first being licensed by the board as a pharmacy technician.
(f)(g)(1)A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (a). A pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the tasks specified in subdivision (b). If a pharmacy technician is performing the tasks specified in subdivision (b), a second pharmacy technician shall be assisting a pharmacist with performing tasks specified in subdivision (a). The ratio of pharmacy technicians performing the tasks specified in subdivision (a) to any additional pharmacist shall not exceed 2:1, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117. This ratio is applicable to all practice settings, except for an inpatient of a licensed health facility, a patient of a licensed home health agency, as specified in paragraph (2), an inmate of a correctional facility of the Department of Corrections and Rehabilitation, and for a person receiving treatment in a facility operated by the State Department of State Hospitals, the State Department of Developmental Services, or the Department of Veterans Affairs.
(2)The board may adopt regulations establishing the ratio of pharmacy technicians performing the tasks specified in subdivision (a) to pharmacists applicable to the filling of prescriptions of an inpatient of a licensed health facility and for a patient of a licensed home health agency. Any ratio established by the board pursuant to this subdivision shall allow, at a minimum, at least one pharmacy technician for a single pharmacist in a pharmacy and two pharmacy technicians for each additional pharmacist, except that this ratio shall not apply to personnel performing clerical functions pursuant to Section 4116 or 4117.
(3)A pharmacist scheduled to supervise a second pharmacy technician may refuse to supervise a second pharmacy technician if the pharmacist determines, in the exercise of his or her their professional judgment, that permitting the second pharmacy technician to be on duty would interfere with the effective performance of the pharmacists responsibilities under this chapter. A pharmacist assigned to supervise a second pharmacy technician shall notify the pharmacist in charge in writing of his or her their determination, specifying the circumstances of concern with respect to the pharmacy or the pharmacy technician that have led to the determination, within a reasonable period, but not to exceed 24 hours, after the posting of the relevant schedule. An entity employing a pharmacist shall not discharge, discipline, or otherwise discriminate against any pharmacist in the terms and conditions of employment for exercising or attempting to exercise in good faith the right established pursuant to this paragraph.
(g)(h)Notwithstanding subdivisions (a) and (b), to (c), inclusive, the board shall by regulation establish conditions to permit the temporary absence of a pharmacist for breaks and lunch periods pursuant to Section 512 of the Labor Code and the orders of the Industrial Welfare Commission without closing the pharmacy. During these temporary absences, a pharmacy technician may, at the discretion of the pharmacist, remain in the pharmacy but may only perform nondiscretionary tasks. The pharmacist shall be responsible for a pharmacy technician and shall review any task performed by a pharmacy technician during the pharmacists temporary absence. This subdivision shall not be construed to authorize a pharmacist to supervise pharmacy technicians in greater ratios than those described in subdivision (f). (g).
(h)(i)The pharmacist on duty shall be directly responsible for the conduct of a pharmacy technician supervised by that pharmacist.
(i)(j)In a health care facility licensed under subdivision (a) of Section 1250 of the Health and Safety Code, a pharmacy technicians duties may include any of the following:
(1)Packaging emergency supplies for use in the health care facility and the hospitals emergency medical system or as authorized under Section 4119.
(2)Sealing emergency containers for use in the health care facility.
(3)Performing monthly checks of the drug supplies stored throughout the health care facility. Irregularities shall be reported within 24 hours to the pharmacist in charge and the director or chief executive officer of the health care facility in accordance with the health care facilitys policies and procedures.
SEC. 5.Section 4192 of the Business and Professions Code is amended to read:4192.(a)Each clinic that makes an application for a license under this article shall show evidence that the professional director is responsible for the safe, orderly, and lawful provision of pharmacy services. In carrying out the professional directors responsibilities, a consulting pharmacist shall be retained to approve the policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist shall be required to visit the clinic regularly and at least quarterly. However, nothing in this section shall prohibit the consulting pharmacist from visiting more than quarterly to review the application of policies and procedures based on the agreement of all the parties approving the policies and procedures.
(b)The consulting pharmacist shall certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of this article. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate. Before July 1 of every odd-numbered year, the consulting pharmacist shall complete a Surgical Clinic Self-Assessment Form as determined by the board as a means to promote compliance through self-examination and education. The self-assessment shall assess the clinics compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the board and posted on its internet website. The professional director of the clinic and consulting pharmacist shall certify on the final page of the Surgical Clinic Self-Assessment Form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form shall be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the board or its designee, upon request.
(c)For the purposes of this article, professional director means a physician and surgeon acting in his or her their capacity as medical director or a dentist or podiatrist acting in his or her their capacity as a director in a clinic where only dental or podiatric services are provided.
(d)Licensed clinics shall notify the board within 30 days of any change in professional director on a form furnished by the board.
SEC. 6.Section 4204 of the Business and Professions Code is amended to read:4204.(a)Each application for a license under Section 4190 shall be made on a form furnished by the board. The form of application for a license under this article shall contain the name and address of the applicant, whether the applicant is licensed, the type of services the facility will offer, the name of its professional director, the name of its administrator, and the name of its consulting pharmacist.
(b)Each initial application shall contain a statement from a consulting pharmacist certifying that the policies and procedures of the clinics drug distribution service, relative to inventories, security procedures, training, protocol development, recordkeeping, packaging, labeling, dispensing, and patient consultation are consistent with the promotion and protection of health and safety of the public. Upon the filing of the application and the payment of a fee in subdivision (s) of Section 4400, the board shall make a thorough investigation to determine whether the applicant and the premises for which application for a license is made qualify for a license. The board shall also determine whether this article has been complied with, and shall investigate all matters directly related to the issuance of the license. The board shall not however, investigate any matters connected with the operation of a premises, including operating hours, parking availability, or operating noise, except those matters relating to the furnishing, sale, or dispensing of drugs or devices. The board shall deny an application for a license if either the applicant or the premises for which application for a license is made do not qualify for a license under this article.
(c)If the board determines that the applicant and the premises for which application for a license is made qualify for a license under Section 4190, the executive officer of the board shall issue a license authorizing the clinic to which it is issued to purchase drugs at wholesale pursuant to Section 4190. The license shall be renewed annually upon payment of a renewal fee prescribed in subdivision (s) of Section 4400 and shall not be transferable. As part of the renewal process the consulting pharmacist shall certify compliance with the quarterly inspections as required in Section 4192. Further, as part of the renewal process of every odd-numbered year, the most recent self-assessment form completed as provided in Section 4192 shall also be provided to the board.
SEC. 7.Section 4301 of the Business and Professions Code is amended to read:4301.The board shall take action against any holder of a license who is guilty of unprofessional conduct or whose license has been issued by mistake. Unprofessional conduct includes, but is not limited to, any of the following:
(a)Procurement of a license by fraud or misrepresentation.
(b)Incompetence.
(c)Gross negligence.
(d)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153 of the Health and Safety Code.
(e)The clearly excessive furnishing of controlled substances in violation of subdivision (a) of Section 11153.5 of the Health and Safety Code. Factors to be considered in determining whether the furnishing of controlled substances is clearly excessive shall include, but not be limited to, the amount of controlled substances furnished, the previous ordering pattern of the customer (including size and frequency of orders), the type and size of the customer, and where and to whom the customer distributes its product.
(f)The commission of any act involving moral turpitude, dishonesty, fraud, deceit, or corruption, whether the act is committed in the course of relations as a licensee or otherwise, and whether the act is a felony or misdemeanor or not.
(g)Knowingly making or signing any certificate or other document that falsely represents the existence or nonexistence of a state of facts.
(h)The administering to oneself, of any controlled substance, or the use of any dangerous drug or of alcoholic beverages to the extent or in a manner as to be dangerous or injurious to oneself, to a person holding a license under this chapter, or to any other person or to the public, or to the extent that the use impairs the ability of the person to conduct with safety to the public the practice authorized by the license.
(i)Except as otherwise authorized by law, knowingly selling, furnishing, giving away, or administering, or offering to sell, furnish, give away, or administer, any controlled substance to an addict.
(j)The violation of any of the statutes of this state, of any other state, or of the United States regulating controlled substances and dangerous drugs.
(k)The conviction of more than one misdemeanor or any felony involving the use, consumption, or self-administration of any dangerous drug or alcoholic beverage, or any combination of those substances.
(l)The conviction of a crime substantially related to the qualifications, functions, and duties of a licensee under this chapter. The record of conviction of a violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of a violation of the statutes of this state regulating controlled substances or dangerous drugs shall be conclusive evidence of unprofessional conduct. In all other cases, the record of conviction shall be conclusive evidence only of the fact that the conviction occurred. The board may inquire into the circumstances surrounding the commission of the crime, in order to fix the degree of discipline or, in the case of a conviction not involving controlled substances or dangerous drugs, to determine if the conviction is of an offense substantially related to the qualifications, functions, and duties of a licensee under this chapter. A plea or verdict of guilty or a conviction following a plea of nolo contendere is deemed to be a conviction within the meaning of this provision. The board may take action when the time for appeal has elapsed, or the judgment of conviction has been affirmed on appeal or when an order granting probation is made suspending the imposition of sentence, irrespective of a subsequent order under Section 1203.4 of the Penal Code allowing the person to withdraw his or her their plea of guilty and to enter a plea of not guilty, or setting aside the verdict of guilty, or dismissing the accusation, information, or indictment.
(m)The cash compromise of a charge of violation of Chapter 13 (commencing with Section 801) of Title 21 of the United States Code regulating controlled substances or of Chapter 7 (commencing with Section 14000) of Part 3 of Division 9 of the Welfare and Institutions Code relating to the Medi-Cal program.
(n)The revocation, suspension, or other discipline by another state of a license to practice pharmacy, operate a pharmacy, or do any other act for which a license is required by this chapter that would be grounds for revocation, suspension, or other discipline under this chapter. Any disciplinary action taken by the board pursuant to this section shall be coterminous with action taken by another state, except that the term of any discipline taken by the board may exceed that of another state, consistent with the boards enforcement guidelines. The evidence of discipline by another state is conclusive proof of unprofessional conduct.
(o)Violating or attempting to violate, directly or indirectly, or assisting in or abetting the violation of or conspiring to violate any provision or term of this chapter or of the applicable federal and state laws and regulations governing pharmacy, including regulations established by the board or by any other state or federal regulatory agency.
(p)Actions or conduct that would have warranted denial of a license.
(q)Engaging in any conduct that subverts or attempts to subvert an investigation of the board.
(r)The selling, trading, transferring, or furnishing of drugs obtained pursuant to Section 256b of Title 42 of the United States Code to any person a licensee knows or reasonably should have known, not to be a patient of a covered entity, as defined in paragraph (4) of subsection (a) of Section 256b of Title 42 of the United States Code.
(s)The clearly excessive furnishing of dangerous drugs by a wholesaler to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities. Factors to be considered in determining whether the furnishing of dangerous drugs is clearly excessive shall include, but not be limited to, the amount of dangerous drugs furnished to a pharmacy that primarily or solely dispenses prescription drugs to patients of long-term care facilities, the previous ordering pattern of the pharmacy, and the general patient population to whom the pharmacy distributes the dangerous drugs. That a wholesaler has established, and employs, a tracking system that complies with the requirements of subdivision (b) of Section 4164 shall be considered in determining whether there has been a violation of this subdivision. This provision shall not be interpreted to require a wholesaler to obtain personal medical information or be authorized to permit a wholesaler to have access to personal medical information except as otherwise authorized by Section 56 and following of the Civil Code. For purposes of this section, long-term care facility has the same meaning given the term in Section 1418 of the Health and Safety Code.
(t)The acquisition of a nonprescription diabetes test device from a person that the licensee knew or should have known was not the nonprescription diabetes test devices manufacturer or the manufacturers authorized distributor as identified in Section 4160.5.
(u)The submission of a reimbursement claim for a nonprescription diabetes test device to a pharmaceutical benefit manager, health insurer, government agency, or other third-party payor when the licensee knew or reasonably should have known that the diabetes test device was not purchased either directly from the manufacturer or from the nonprescription diabetes test device manufacturers authorized distributors as identified in Section 4160.5.
(v)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacists ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
(w)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
(x)Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations.
(y)Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
SEC. 8.Section 4316.5 is added to the Business and Professions Code, to read:4316.5.Notwithstanding any other law, the board may assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the board, not to exceed five thousand dollars ($5,000) for each occurrence pursuant to a citation issued by the board.
SEC. 9.The Legislature finds and declares that Section 2 of this act, which adds Section 4113.1 to the Business and Professions Code, imposes a limitation on the publics right of access to the meetings of public bodies or the writings of public officials and agencies within the meaning of Section 3 of Article I of the California Constitution. Pursuant to that constitutional provision, the Legislature makes the following findings to demonstrate the interest protected by this limitation and the need for protecting that interest:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policy makers to advance patient safety.
SEC. 10.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
|
Date
|
Status
|
|---|---|
| Oct 8, 2023 | Chaptered by Secretary of State - Chapter 470, Statutes of 2023. |
| Oct 8, 2023 | Approved by the Governor. |
| Sep 21, 2023 | Enrolled and presented to the Governor at 3:30 p.m. |
| Sep 14, 2023 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 59. Noes 8. Page 3560.). |
| Sep 13, 2023 | In Assembly. Concurrence in Senate amendments pending. |
| Sep 13, 2023 | Read third time. Passed. Ordered to the Assembly. (Ayes 30. Noes 9. Page 2758.). |
| Sep 11, 2023 | Read second time. Ordered to third reading. |
| Sep 8, 2023 | Read third time and amended. Ordered to second reading. |
| Aug 22, 2023 | Read second time. Ordered to third reading. |
| Aug 21, 2023 | From committee: Be ordered to second reading pursuant to Senate Rule 28.8. |
| Jul 13, 2023 | Read second time and amended. Re-referred to Com. on APPR. |
| Jul 12, 2023 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 9. Noes 2.) (July 11). |
| Jul 5, 2023 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on JUD. |
| Jul 3, 2023 | From committee: Do pass and re-refer to Com. on JUD. (Ayes 8. Noes 3.) (July 3). Re-referred to Com. on JUD. |
| Jun 29, 2023 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B., P. & E. D. |
| Jun 14, 2023 | Referred to Coms. on B., P. & E. D. and JUD. |
| Jun 1, 2023 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Jun 1, 2023 | Read third time. Passed. Ordered to the Senate. (Ayes 57. Noes 10. Page 2125.) |
| Jun 1, 2023 | Assembly Rule 69 suspended. (Ayes 61. Noes 15. Page 2118.) |
| May 31, 2023 | Read third time and amended. Ordered to third reading. (Page 1954.) |
| May 4, 2023 | Read second time. Ordered to third reading. |
| May 3, 2023 | From committee: Do pass. (Ayes 12. Noes 2.) (May 3). |
| Apr 20, 2023 | Re-referred to Com. on APPR. |
| Apr 19, 2023 | Read second time and amended. |
| Apr 18, 2023 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 11. Noes 1.) (April 18). |
| Mar 2, 2023 | Referred to Com. on B. & P. |
| Feb 17, 2023 | From printer. May be heard in committee March 19. |
| Feb 16, 2023 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Sep 14, 2023 | AB 1286 Haney Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Sep 13, 2023 | Assembly 3rd Reading AB1286 Haney et al. By Smallwood-Cuevas | Senate Floor |
Passed |
|
| Jul 11, 2023 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] | Senate Standing Committee on Judiciary |
Passed |
|
| Jul 3, 2023 | Do pass, but first be re-referred to the Committee on [Judiciary] | Senate Standing Committee on Business, Professions and Economic Development |
Passed |
|
| Jun 1, 2023 | AB 1286 Haney Assembly Third Reading | Assembly Floor |
Passed |
|
| May 3, 2023 | Do pass. | Assembly Standing Committee on Appropriations |
Passed |
|
| Apr 18, 2023 | Do pass as amended and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Business and Professions |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| Albertson's Companies | * Against Unless Amend | Jul 3, 2023 |
| California Alliance For Retired Americans | ** Support | |
| California Community Pharmacy Coalition | ** Against | |
| California Health System Pharmacists | ** Support | |
| California Labor Federation | ** Support | |
| California Medical Association | * Against Unless Amend | Apr 18, 2023 |
| California Pharmacists Association | ** Support | |
| California Retailers Association | ** Against | |
| California State Board of Pharmacy | ** Support | |
| Consumer Protection Policy Center | ** Support | |
| Ralphs Grocery Company | * Support | Jul 11, 2023 |
| Rite Aid Corporation | * Against | Jul 3, 2023 |
| United Food And Commercial Workers, Western States Council | ** Support | |
| University of the Pacific School of Pharmacy | * Support | Jul 3, 2023 |
| Wallgreens | * Against | Jul 3, 2023 |
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 1286
Author:(Haney)
As Amended Ver:September 8, 2023
Majority vote
SUMMARY
Authorizes a pharmacist-in-charge to make staffing decisions in a pharmacy; requires the pharmacist-in-charge or pharmacist on duty to notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm, requires store management to take immediate and reasonable steps to address and resolve those conditions, and authorizes the California State Board of Pharmacy (BOP) to close a pharmacy if the conditions aren't resolved; requires a chain community pharmacy to be staffed with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services, except as provided; authorizes pharmacy technicians with specified training to perform additional tasks under supervision, including administering influenza and COVID-19 vaccines and epinephrine and performing specimen collection for laboratory tests; requires community pharmacies to report medication errors; and requires consulting pharmacists to complete a Surgical Clinic Self-Assessment Form every other year, among other provisions.
Senate Amendments
- Remove a pharmacist-in-charge's authority to close a pharmacy under certain conditions and instead empowers the BOP to issue an order to the pharmacy to immediately cease and desist those pharmacy operations that are affected by the conditions at issue if store management has not resolved the conditions within 24 hours.
- Revise the examples of conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
- Require a pharmacy technician to be certified in basic life support prior to engaging in the additional tasks authorized by this bill and require them to perform those tasks under the direct supervision and control of a pharmacist.
- Remove a pharmacist on duty's authority to close a chain community pharmacy if staffing is inadequate to safely fill or dispense prescriptions or provide other patient care services.
- Strike the phrase "or tend to subvert" from the new actions or conduct that would be declared unprofessional conduct.
- Authorizes the BOP to publish deidentified information compiled from the data in medication error reports.
- Exempts the Department of Corrections and Rehabilitation from provisions of this bill.
- Allow for a community pharmacy to report medication errors through a designated third party, including a component patient safety organization and defines "medication error."
- Expand on the cases where the BOP shall not take action against a pharmacy for failing to be staffed at all times with at least one clerk or pharmacy technician.
COMMENTS
Pharmacist-in-Charge Authority. Under the Pharmacy Law, pharmacists licensed by the BOP can be directly employed by retailers and other community pharmacies. This has remained the case despite increasing recognition of their professional training and authority to exercise a meaningful degree of clinical judgement, which has resulted in numerous scope expansions for the profession. However, each pharmacy must designate a "pharmacist-in-charge," subject to approval by the BOP. This pharmacist-in-charge is responsible for a pharmacy's compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would expand the autonomy of the pharmacist-in-charge to make certain staffing and pharmacy operations decisions that the pharmacist-in-charge believes to be in the best interest of personnel and patients. First, this bill would authorize the pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist's ability to practice competently and safely. This authority would be delegated to the pharmacist on duty if the pharmacist-in-charge is not available.
Second, this bill would empower the pharmacist-in-charge or pharmacist on duty to report conditions to the BOP that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. If store management does not resolve those conditions within 24 hours, the pharmacist-in-charge or pharmacist would be required to notify the BOP. The BOP would then be authorized to issue an order to the pharmacy to immediately cease and desist those pharmacy operations that are affected by the conditions at issue. This cease and desist order would remain in effect until either the executive officer of the BOP determines that the conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff have been abated, or for no more than 30 days, whichever date is earlier.
Pharmacy Staffing. Pharmacists working in chain community pharmacies, particularly those co-located with other retail and grocery stores, have historically complained that it is common for a pharmacist to be the only employee assigned to the pharmacy area. According to previously conducted surveys, 83% of pharmacists report being left alone during the workday for an average period of four hours. Within this population, the survey indicated that a high percentage of pharmacists stated that they do not have enough time to fulfill their professional functions to the extent that they believed necessary. These pharmacists have argued that instead of providing their core pharmacy services, much of their time is instead spent performing clerical tasks and performing non-pharmacy activities on behalf of the business.
Statute authorizes an unlicensed employee to provide purely clerical assistance to a pharmacist, and for a pharmacy technician licensed by the BOP to assist a pharmacist with a number of more sensitive pharmacy service activities. The Pharmacy Law imposes a strict cap on the number of pharmacy technicians who may be assigned to assist a pharmacist; a single pharmacist may be assisted by no more than a single pharmacy technician. Many community pharmacy owners believe that this restrictive law, referred to as the "pharmacist/pharmacy technician ratio," frequently results in inadequate staff support for pharmacists and an inability for some community pharmacies to adequately meet the demands of their patients. Several efforts to increase this ratio over the years have failed to pass.
In 2018, SB 1442 (Wiener) was enacted to prohibit community pharmacies from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee is made available to assist the pharmacist at all times. An exception was included for situations where another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, and the pharmacy takes all reasonable action to make another employee available to assist the pharmacist.
Representatives of pharmacists who work in community pharmacies have complained that the 2018 legislation has not been effectively implemented due to deficiencies in the law. These organizations report that pharmacists are often still left alone without support staff in many cases where additional staff is needed. This bill would seek to rectify this issue by expressly requiring that a chain community pharmacy be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services, unless waived by the pharmacist on duty. This bill would additionally provide that where staffing of pharmacist hours does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
Pharmacy Technician Scope. Over the past several years, the BOP has voted to support the development of a legislative proposal to create a new mid-level practitioner in pharmacy settings. This proposed "advanced pharmacy technician" would be authorized to carry out certain duties that pose a relatively low risk of patient harm but may currently only be performed by pharmacists, allowing a pharmacist to spend more time engaged in patient care. While the BOP has formally pursued legislation to establish a new license category for advanced pharmacy technicians and enable these mid-level practitioners to serve in pharmacies, no legislative attempt has been successful to date.
During the COVID-19 pandemic, the Governor signed an executive order that created a new process for boards and the public to request waivers of requirements related to healing arts professional licensing through the Department of Consumer Affairs (DCA). Through this waiver process, the DCA issued multiple waivers of law to authorize various healing arts licensees to order and administer the COVID-19 vaccine. These waivers have extended to pharmacy technicians, as well as pharmacists and other healing arts professionals, consistent with the federal Public Readiness and Emergency Preparedness (PREP) Act. On August 4, 2021, the federal Health and Human Services Agency issued an amendment to the Public Readiness and Emergency Preparedness (PREP) Act to extend coverage to pharmacy technicians with proper training to administer seasonal flu vaccines to adults in addition to the COVID-19 vaccine.
This bill would authorize pharmacy technicians to prepare and administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for CLIA-waived tests, receive prescription transfers, and accept clarification on prescriptions. The pharmacy technicians would also be required to complete at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technician's injection technique. The pharmacy technician would also be required to be certified in basic life support. A pharmacy technician who qualifies to perform the additional tasks would then not count in the Pharmacy Law's 1:1 ratio, and another pharmacy technician would be required to assist with other tasks.
Surgical Clinic Self-Assessment Forms. The Pharmacy Law requires certain clinics, including surgical clinics, accredited outpatient settings, and certified ambulatory surgical centers to obtain a license from the BOP. These clinics are required to retain a consulting pharmacist to approve the clinic's policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist is required to visit the clinic regularly and at least quarterly. The consulting pharmacist is then required to certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of the Pharmacy Law. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate.
This bill would additionally require each consulting pharmacist for a clinic to complete a Surgical Clinic Self-Assessment Form, as determined by the BOP, as a means to promote compliance through self-examination and education. The self-assessment is intended to assess the clinic's compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the BOP and posted on its website. The professional director of the clinic and consulting pharmacist would be required to certify that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form would then be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the BOP or its designee, upon request. This process would be required before July 1 on each odd-numbered year and would be incorporated into the consulting pharmacist's renewal process, along with certification of compliance with quarterly inspection requirements.
Medication Errors. The BOP has listed medication error as the number one violation resulting in a citation in nearly every year within the last several years. According to the Journal of the American Medical Association, 46 percent of adults cannot understand the information listed on their prescription drug labels. Furthermore, the Institute of Medicine of the National Academies indicates that medication errors are among the most common medical errors, harming at least 1.5 million people annually.
This bill would seek to improve the state's understanding of the causes of medication errors by requiring community pharmacies to report all medication errors to an entity approved by the BOP. A community pharmacy or its designated third party would be required to submit the report no later than 14 days following the date of discovery of the error. Reports would be deemed confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act, though the BOP would be authorized to publish deidentified data. The BOP would not be allowed to subject a community pharmacy to discipline or other enforcement action based solely on the report; however, if the BOP receives other information regarding the medication error, that may serve as basis for enforcement by the BOP.
Unprofessional Conduct. The BOP's Enforcement Unit regularly engages in investigations of licensees that may result in disciplinary action, as well as cases involving unlicensed activity. Over 12,100 investigations were completed from fiscal year (FY) 2015/16 through FY 2018/19, with 1,335 referrals for formal discipline resulting in the revocation or surrender of 854 licenses and 462 licenses placed on probation. In addition, the BOP issued a total of 7,223 citations. On average, the BOP receives around 3,500 complaints per year. These complaints are then categorized into priorities based on the potential risk to public health and safety.
The Pharmacy Law requires the BOP to take action against any licensee who is guilty of unprofessional conduct. Statute provides that unprofessional conduct includes various specified acts and omissions, including incompetence, gross negligence, inappropriate furnishing of controlled substances, and other violations of law. Existing law specifies that engaging in any conduct that subverts or attempts to subvert an investigation of the BOP is unprofessional conduct. This bill would further add to the list of what constitutes unprofessional conduct, including actions or conduct that subvert the efforts of a pharmacist to comply with laws and regulations or exercise professional judgment.
According to the Author
"Community chain pharmacies and the pharmacists who work for them are instrumental in delivering care to Californians. However, recent news reports have highlighted alarming medication errors in this setting—including errors that have led to death. The root cause of medication errors in the community chain setting can be tied to pharmacy working conditions, like insufficient staffing, unsanitary conditions, or lack of autonomy to make clinical decisions in the best interest of the patient. Unfortunately, there is no requirement under current law for pharmacies to track medication errors or to consider the pharmacy working conditions that lead to medication errors. To address the root cause of medication errors and major faults in Pharmacy Law, AB 1286 will establish a first in the nation mandatory reporting of medication errors to allow for robust evaluation of the causes of medication errors. It also gives licensed pharmacy staff autonomy over their working conditions so they can provide better patient care and services for Californians."
Arguments in Support
The United Food and Commercial Workers Western States Council (UFCW) supports this bill. According to UFCW: "The Board charged by law with protecting patients who need prescription medicines to stay alive, heal, and reduce suffering is telling this Legislature Californians are broadly and deeply at-risk of death and needless anguish. The cause? Nothing more than publicly traded chain pharmacies placing short-term profits over the lives of California families. This bill is one of the most important public health bills pending this year. It is based on careful study, is proportional, and, according to the expert regulator, urgently needed."
Arguments in Opposition
The California Community Pharmacy Coalition opposes this bill, writing: "AB 1286 (Haney) as currently written, will have a detrimental impact on patient access to pharmacy services. Instead, the bill should be modified to expand the pharmacist to pharmacy technician ratio, have the Board of Pharmacy work collaboratively with pharmacists and pharmacy companies to develop plans and perimeters to address situations where a pharmacy might need to limit services or close during emergencies and lastly to address medication errors through a more reasonable approach to reporting."
FISCAL COMMENTS
According to the Senate Appropriations Committee, pursuant to Senate Rule 28.8, negligible state costs.
VOTES:
ASM BUSINESS AND PROFESSIONS: 11-1-6
YES: Berman, Bonta, Gipson, Grayson, Irwin, Jackson, Lee, Lowenthal, McKinnor, Stephanie Nguyen, Ting
NO: Dixon
ABS, ABST OR NV: Flora, Alanis, Alvarez, Chen, McCarty, Joe Patterson
ASM APPROPRIATIONS: 12-2-2
YES: Holden, Bryan, Calderon, Wendy Carrillo, Mike Fong, Hart, Lowenthal, Papan, Pellerin, Robert Rivas, Weber, Wilson
NO: Megan Dahle, Dixon
ABS, ABST OR NV: Mathis, Sanchez
ASSEMBLY FLOOR: 57-10-13
YES: Addis, Aguiar-Curry, Alvarez, Arambula, Bauer-Kahan, Bennett, Berman, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Connolly, Mike Fong, Friedman, Garcia, Gipson, Grayson, Haney, Hart, Holden, Irwin, Jackson, Jones-Sawyer, Kalra, Lee, Low, Lowenthal, Maienschein, McCarty, McKinnor, Muratsuchi, Ortega, Papan, Pellerin, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Ward, Weber, Wicks, Wilson, Wood, Zbur, Rendon
NO: Alanis, Chen, Megan Dahle, Dixon, Essayli, Flora, Gallagher, Hoover, Joe Patterson, Wallis
ABS, ABST OR NV: Bains, Boerner, Davies, Vince Fong, Gabriel, Lackey, Mathis, Stephanie Nguyen, Pacheco, Jim Patterson, Petrie-Norris, Blanca Rubio, Sanchez
SENATE FLOOR: 30-9-1
YES: Allen, Archuleta, Ashby, Atkins, Becker, Blakespear, Bradford, Cortese, Dodd, Durazo, Eggman, Glazer, Gonzalez, Hurtado, Laird, Limón, McGuire, Menjivar, Min, Newman, Padilla, Portantino, Roth, Rubio, Skinner, Smallwood-Cuevas, Stern, Umberg, Wahab, Wiener
NO: Alvarado-Gil, Dahle, Grove, Jones, Nguyen, Niello, Ochoa Bogh, Seyarto, Wilk
ABS, ABST OR NV: Caballero
UPDATED
VERSION: September 8, 2023
CONSULTANT: Robert Sumner / B. & P. / (916) 319-3301 FN: 0002451
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 1286 |
THIRD READING
Bill No: AB 1286
Author: Haney (D), et al.
Amended: 9/8/23 in Senate
Vote: 21
SENATE BUS., PROF. & ECON. DEV. COMMITTEE: 8-3, 7/3/23
AYES: Roth, Archuleta, Ashby, Becker, Eggman, Glazer, Smallwood-Cuevas, Wahab
NOES: Nguyen, Niello, Wilk
NO VOTE RECORDED: Alvarado-Gil, Dodd
SENATE JUDICIARY COMMITTEE: 9-2, 7/11/23
AYES: Umberg, Allen, Ashby, Caballero, Durazo, Laird, Min, Stern, Wiener
NOES: Wilk, Niello
SENATE APPROPRIATIONS COMMITTEE: Senate Rule 28.8
ASSEMBLY FLOOR: 57-10, 6/1/23 - See last page for vote
SUBJECT: Pharmacy
SOURCE: California State Board of Pharmacy
DIGEST:
This bill provides the Board of Pharmacy (Board) with cease and desist authority for specified conditions present in a pharmacy; updates the authority for pharmacy technicians to undertake certain tasks according to qualification and supervision requirements; requires a community pharmacy to report medication errors to a Board-approved entity; requires a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician dedicated to pharmacy-related services; adds additional violations to those included in unprofessional conduct and; authorizes the Board to assess fines and issue orders of abatement to unlicensed entities providing services that require licensure.
Senate Floor Amendments of 9/8/23 exempt Department of Corrections and Rehabilitation facility pharmacies from various staffing and other provisions outlined in the bill; authorize a pharmacy owner rather than licensee to close a pharmacy under specified circumstances; update how a community pharmacy must report medication errors and update the definition of medication error for purposes of reporting; clarify how the Board can publish deidentified medication error case summary information; specify that an entity approved by the Board to receive medication error reporting must have experience analyzing medication errors in outpatient settings; clarify that an outpatient hospital pharmacy does not have to report medication errors pursuant to requirements outlined in the bill if the error meets the requirements of an adverse event that is subject to reporting to other state agencies; add specified conditions for when the Board cannot take action against a chain community pharmacy that is not staffed with at least one clerk or pharmacy technician and; make various other technical and conforming changes.
ANALYSIS:
Existing law:
- Defines a pharmacy technician (PT) as an individual who assists a pharmacist in a pharmacy in the performance of his or her related duties, which shall include packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. Clarifies that a PT can only perform the above tasks with a pharmacist on duty. Prohibits a PT from performing any act requiring the exercise of professional judgment by a pharmacist. (BPC §§ 4038, 4115 (a-c))
- Requires the Board to adopt regulations to specify tasks that a PT may perform under the supervision of a pharmacist. Provides that any pharmacy that employs a PT shall do so in conformity with the regulations adopted by the Board. (BPC § 4115 (d))
- Establishes that a pharmacy with only one pharmacist shall have no more than one PT (1:1). Establishes that any additional pharmacists shall oversee no more than two PTs, except if those PTs are performing specified clerical functions. Establishes that this ratio applies to all practice settings except for an inpatient of a health facility, a patient of a home health agency, an inmate of a correctional facility, or for a person receiving treatment through specified state services. (BPC § 4115 (f)(1))
- Authorizes pharmacists and pharmacies to perform, under specified conditions, particular tests that are classified as waived under CLIA and makes conforming changes and requires a pharmacy and a pharmacist-in-charge to maintain documents related to testing and compliance. (BPC §§ 1206, 1209, 4119.10)
- Requires the Board to establish regulations to permit the temporary absence of a pharmacist for breaks and lunch periods without closing the pharmacy.
(BPC § 4115 (g)) - Establishes that the pharmacist on duty is directly responsible for the conduct of a PT that he or she supervises. (BPC § 4115 (h))
- Specifies that a “chain community pharmacy” means a chain of 75 or more stores in California under the same ownership, and an “independent community pharmacy” means a pharmacy owned by a person or entity who owns no more than four pharmacies in California. (BPC § 4001 (c))
- Prohibits a community pharmacy from requiring a pharmacist to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless another employee, as specified, is made available to assist the pharmacist at all times. (BPC § 4113.5)
- Provides that unprofessional conduct includes, but is not limited to: procurement of a license by fraud or misrepresentation; incompetence; gross negligence; the clearly excessive furnishing of controlled substances, as specified; the clearly excessive furnishing of controlled substances, as specified, among other things. (BPC § 4301)
- Requires every clinical laboratory to operate under the overall operation and administration of a laboratory director. (BPC § 1206.5(a), 1206.5(b), 1206.5(c))
This bill provides the Board with cease and desist authority for specified conditions present in a pharmacy; updates the authority for pharmacy technicians to undertake certain tasks according to qualification and supervision requirements; requires a community pharmacy to report medication errors to a Board-approved entity; requires a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician dedicated to pharmacy-related services; adds additional violations to those included in unprofessional conduct and; authorizes the Board to assess fines and issue orders of abatement to unlicensed entities providing services that require licensure.
Background
The Board regulates the practice of pharmacies, pharmacists, interns, PTs, and others, including those who are involved with the wholesale or manufacturer of drugs and medical devices, but not required to hold a pharmacist license. The Board also regulates all types of firms that distribute prescription drugs and devices in California, including community pharmacies and those located in hospitals, clinics, home and community support services facilities, and out-of-state mail order pharmacies that fill prescriptions and deliver them in California. In Fiscal Year 2019/2020, there were approximately 143,242 licensees under the Board’s jurisdiction.
According to the findings and declarations in current law, pharmacists are health care professionals whose training and experience play a vital role in protecting public health. Pharmacists are legally and ethically bound to advise their patients, physicians, and other health practitioners on the selection, dosages, interactions, and side effects of medications as well as monitor the health and progress of those patients to ensure that they are using their medications safely and effectively. According to BPC § 4001.1, the highest priority for the regulation of pharmacists is protection of the public.
Depending on their setting, pharmacists’ scope of practice can diminish or expand. For example, pharmacists in any setting may administer the following tests and medications: toxicology, drug-therapy, and disease management and protection; over the counter tests for blood glucose and hemoglobin levels; hormonal contraceptives; prescription medications that do not require a prescription for travel purposes; nicotine replacement products; HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP); routine and the COVID-19 vaccination; skin puncture if the test is CLIA-waived and a person could perform the test at home themselves; certain dialysis drugs; and opioid antigen injections.
However, other tests, medications, and procedures require pharmacists to practice: in a health care facility; in a licensed home health agency; in a licensed correctional clinic; in a licensed clinic in which there is physician oversight; with a provider who contracts with a licensed health care service plan with regard to the care or services provided to the enrollees of that health care service plan; or with a physician, in accordance with the policies, procedures, or protocols of that facility, agency, clinic, service plan, or physician. Settings generally offer varying degrees of supervision by medical professionals depending on the setting. In these settings, pharmacists may: complete drug-therapy patient assessments (such as taking temperature, pulse, and respiration); order drug-therapy related laboratory tests; administer drugs and biologics by injection; initiate and adjust drug regime by patient provider.
In a recent effort to support pharmacists in specific work environments, SB 1442 (Wiener, Chapter 569, Statutes of 2018) prohibited a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless another employee is made available to assist the pharmacist at all times.
Most health professions require that licensees of the profession(s) in question are owners, shareholders, or otherwise have authority over other licensees within a company setting. For example, the Medical Board of California explains that this “policy expressed in Business and Professions Code section 2400 against the corporate practice of medicine is intended to prevent unlicensed persons from interfering with or influencing the physician’s professional judgment.” The theory is that licensed members of a profession have just as much incentive to choose ethical integrity over profit as their employees, as all are subject to the same licensing rules and regulations. Chiropractors, dentists, and speech language pathologists are among the other professions that have a similar policy. Existing law does not prevent unlicensed persons from being shareholders or corporate owners over pharmacists or pharmacy technicians.
Based on a workplace board survey described above, the Board says the following regarding this bill: “Assembly Bill 1286 is a culmination of a yearlong effort undertaken by an ad hoc committee specifically focused on evaluating medication errors, working conditions, and the intersection of the two. This committee was formed after the Board considered survey results from its own workforce survey that included some startling findings including 83% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide appropriate patient consultation, while 32% of pharmacists working in community independent pharmacies indicated same. As part of the Committee’s process, members heard from experts in the field, learned about authorities in other jurisdictions, and gained an understanding about findings and activities under way at the national level. It is incumbent upon the Board to act now on these findings to promote patient care.”
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
SUPPORT: (Verified 9/8/23)
California State Board of Pharmacy (source)
California Alliance for Retired Americans
California Labor Federation
California Health System Pharmacists
California Pharmacists Association
Consumer Protection Policy Center
United Food and Commercial Workers, Western States Council
OPPOSITION: (Verified 9/8/23)
California Community Pharmacy Coalition
California Retailers Association
ARGUMENTS IN SUPPORT: Supporters generally write this bill is a culmination of many years of effort to address medication errors, working conditions, and the intersection of the two, as well as other issues. Supporters also write that they support safe working conditions for pharmacist professionals and patients.
ARGUMENTS IN OPPOSITION: Opposition generally argues that pharmacist-in-charge authority to close a pharmacy will have a detrimental impact on patient access to their medications; staffing floor requirements are too rigid and unrealistic; the pharmacist to pharmacy technician ratio should be revised; and medication error reporting should not be restricted to one organization.
ASSEMBLY FLOOR: 57-10, 6/1/23
AYES: Addis, Aguiar-Curry, Alvarez, Arambula, Bauer-Kahan, Bennett, Berman, Bonta, Bryan, Calderon, Juan Carrillo, Wendy Carrillo, Cervantes, Connolly, Mike Fong, Friedman, Garcia, Gipson, Grayson, Haney, Hart, Holden, Irwin, Jackson, Jones-Sawyer, Kalra, Lee, Low, Lowenthal, Maienschein, McCarty, McKinnor, Muratsuchi, Ortega, Papan, Pellerin, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Santiago, Schiavo, Soria, Ta, Ting, Valencia, Villapudua, Waldron, Ward, Weber, Wicks, Wilson, Wood, Zbur, Rendon
NOES: Alanis, Chen, Megan Dahle, Dixon, Essayli, Flora, Gallagher, Hoover, Joe Patterson, Wallis
NO VOTE RECORDED: Bains, Boerner, Davies, Vince Fong, Gabriel, Lackey, Mathis, Stephanie Nguyen, Pacheco, Jim Patterson, Petrie-Norris, Blanca Rubio, Sanchez
Prepared by: Dana Shaker / B., P. & E.D. /
9/11/23 12:00:25
**** END ****
Senator Thomas Umberg, Chair
2023-2024 Regular Session
Bill No: AB 1286 (Author:Haney)
Version: July 5, 2023
Hearing Date: July 11, 2023
Fiscal: Yes
Urgency: No
Consultant: AM
SUBJECT
Pharmacy
DIGEST
This bill provides the Board of Pharmacy (Board) with cease and desist authority for specified conditions present in a pharmacy, updates the authority for pharmacy technicians to undertake certain tasks according to qualification and supervision requirements, requires certain medication error reporting, and authorizes pharmacy closure by a pharmacist if certain circumstances exist. The bill requires reports regarding medication errors be kept and reported, as provided, and specifies that these reports are not subject to discovery, subpoena, or disclosed pursuant to the California Public Records Act.
EXECUTIVE SUMMARY
Following national media reports on pharmacy working conditions and medication errors, and in response to issues identified as part of the Board’s sunset review, the Board conducted a survey of community pharmacists. Survey results highlighted significant challenges facing pharmacists working in community pharmacies, most notably in community chain pharmacies. In response to the findings, the Board established an ad hoc committee to evaluate the issue of medication errors, workforce challenges, and the intersection between the two. This bill is a result of those efforts.
The bill is sponsored by the California State Board of Pharmacy and is supported by California Labor Federation, AFL-CIO, California Pharmacists Association, United Food and Commercial Workers, Western States Council. It is opposed by the California Community Pharmacy Coalition. This bill passed the Senate Business, Professions and Economic Development Committee on a vote of 8 to 3.
PROPOSED CHANGES TO THE LAW
Existing law:
- Establishes the Board in the Department of Consumer Affairs to administer and enforce the Pharmacy Law, which provides for the licensure and regulation of pharmacists, pharmacies, and pharmacy technicians in the state. (Bus. & Prof. Code) § 4000 et. seq.)
- Requires a pharmacy with only one pharmacist to have no more than one pharmacy technician (PTs). Provides that any additional pharmacists can oversee no more than two PTs, except if those PTs are performing specified clerical functions. Establishes that this ratio applies to all practice settings except for an inpatient of a health facility, a patient of a home health agency, an inmate of a correctional facility, or for a person receiving treatment through specified state services. (Bus. & Prof. Code §4115(f)(1).)
- Authorizes a pharmacist scheduled to supervise a second PT to refuse the duty if he or she determines that the additional PT would interfere with the responsibilities of the pharmacist. (Bus. & Prof. Code § 4115(f)(3).)
- Establishes that the pharmacist on duty is directly responsible for the conduct of a PT that they supervise. (Bus. & Prof. Code § 4115 (h))
- Prohibits a community pharmacy from requiring a pharmacist to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless another employee, as specified, is made available to assist the pharmacist at all times. (Bus. & Prof. Code § 4113.5)
- Prohibits a chain community pharmacy from establishing a quota to measure or evaluate a pharmacist or pharmacy technician’s performance of duties, prohibits a chain community pharmacy from communicating the existence of quotas to employees or those it contracts with, and authorizes the Board of Pharmacy to take enforcement action against a community pharmacy that establishes a quota related to a pharmacist or pharmacy technician duties, unless by clear and convincing evidence the community pharmacy can demonstrate the violation was contrary to its policy. (Bus. & Prof. Code § 4113.7.)
- Provides, pursuant to the California Constitution, that the people have the right of access to information concerning the conduct of the people’s business, and, therefore, the meetings of public bodies and the writings of public officials and agencies are required to be open to public scrutiny. (Cal. const. art. I, § 3(b)(1).)
- Requires a statute to be broadly construed if it furthers the people’s right of access, and narrowly construed if it limits the right of access. (Cal. const. art. I, § 3(b)(1).)
- Requires a statute that limits the public’s right of access to be adopted with findings demonstrating the interest protected by the limitation and the need for protecting that interest. (Cal. const. art. I, § 3(b)(1).)
- Governs the disclosure of information collected and maintained by public agencies pursuant to the CPRA. (Gov. Code §§ 7920.000 et seq.)
- States that the Legislature, mindful of the individual right to privacy, finds and declares that access to information concerning the conduct of the people’s business is a fundamental and necessary right of every person in this state. (Gov. Code § 7921.000.)
- Defines “public records” as any writing containing information relating to the conduct of the public’s business prepared, owned, used, or retained by any state or local agency regardless of physical form or characteristics. (Gov. Code § 7920.530.)
- Provides that all public records are accessible to the public upon request, unless the record requested is exempt from public disclosure. (Gov. Code § 7922.530.)
This bill:
- Authorizes the pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist’s ability to practice competently and safely. Specifies that, if the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed.
- Requires the pharmacist-in-charge or pharmacist on duty to immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. States store management will take immediate and reasonable steps to address and resolve the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. States that if conditions are not resolved within 24 hours, the pharmacist-in-charge or pharmacists on duty will ensure the board is timely notified.
- Specifies that conditions which present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, among other things, hazards that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
- Requires a community pharmacy to report all medication errors to a Board-approved entity no later than 14 days following the date of the discovery of the error. Specifies that those reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the CPRA.
COMMENTS
- Stated need for the bill
The author writes:
Community chain pharmacies and the pharmacists who work for them are instrumental in delivering care to Californians. However, recent news reports have highlighted alarming medication errors in this setting—including errors that have led to death. The root cause of medication errors in the community chain setting can be tied to pharmacy working conditions, like insufficient staffing, unsanitary conditions, or lack of autonomy to make clinical decisions in the best interest of the patient. Unfortunately, there is no requirement under current law for pharmacies to track medication errors or to consider the pharmacy working conditions that lead to medication errors. To address the root cause of medication errors and major faults in Pharmacy Law, AB 1286 will establish a first in the nation mandatory reporting of medication errors to allow for robust evaluation of the causes of medication errors. It also gives licensed pharmacy staff autonomy over their working conditions so they can provide better patient care and services for Californians.
- Limitation on the access to medication error reports
The brunt of this bill relates to the responsibility of the pharmacist in charge, staffing requirements, tasks a PT is authorized to perform, and actions that constitute unprofessional conduct under the Pharmacy Law. These issues fall within the jurisdiction of the Senate Business Professions and Economic Development Committee; that Committee’s analysis of this bill is incorporated herein by reference.
For this Committee’s purposes, the bill requires a community pharmacy to report all medication errors to a Board-approved entity no later than 14 days following the date of the discovery of the error. The Board notes that this provision will ensure that the Board has the necessary tools to protect California patients by providing the Board the authority to establish a mandatory medication error reporting requirement that will provide licensees, the Legislature, and the Board with a transparent understanding of the frequency of medication errors, causes of errors, and shared learning, with the goal of reducing medication errors from occurring in community pharmacies. These provisions are intended to build upon existing requirements under the Pharmacy Law that requires each pharmacy to establish a quality assurance program that, at a minimum, documents medication errors attributable, in whole or in part, to the pharmacy or its personnel. (Bus. & Prof. Code § 4125.) The purpose of the quality assurance program is to assess errors that occur in the pharmacy in dispensing or furnishing prescription medications so that the pharmacy may take appropriate action to prevent a recurrence. Records generated for and maintained as a component of a pharmacy’s on going quality assurance program are to be considered peer review documents and not subject to discovery in any arbitration, civil, or other proceeding, except as provided, due to the sensitive information regarding patients that can be contained within.
In recognition that the information contained in these medication error reports contains sensitive patient information, the bill provides that these reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the CPRA. California generally recognizes that public access to information concerning the conduct of the people’s business is a fundamental and necessary right. At the same time, the state recognizes that this right must be balanced against the right to privacy. The general right of access to public records may, therefore, be limited where records include personal information. In light of the sensitive nature of information contained in medication error reports, the potential limiting of access to public records in this bill seems warranted.
- Proposed amendment
The author and sponsor have indicated that the intent of the error medication reporting is to provide licensees, the Legislature, and the Board with a transparent understanding of the frequency of medication errors. However, the current language in the bill provides that the reports are confidential and not subject to disclosure, but does not grant the Board the authority to release information gleaned from the data in the reports so long as no identifying information is disclosed. As such, the author may wish to amend the bill to authorize the Board to publish deidentified information compiled from the data in the reports.
The specific amendment is:[1]
Section 4113.1 as added to the Business and Professions Code, is amended to read:
4113.1.
(a) A community pharmacy licensed pursuant to this article shall report all medication errors to an entity approved by the board. A community pharmacy shall submit the report no later than 14 days following the date of discovery of the error. These reports are deemed confidential and are not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act (Division 10 (commencing with Section 7920.000) of Title 1 of the Government Code). Code), except that the board may publish deidentified information compiled from the data in the reports. The community pharmacy shall maintain records demonstrating compliance with this requirement for three years and shall make these records immediately available at the request of an inspector. A medication error report made pursuant to this section shall not be subject to discipline or other enforcement action by the board based solely on the report. However, if the board receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the board.
(b) For purposes of this section, “community pharmacy” includes any pharmacy that dispenses medication to an outpatient.
- Statements in support
The California Board of Pharmacy, sponsor of the bill, writes:
As part of the Board’s Sunset Review process in November 2020, oversight committees asked the Board if there were opportunities for statutory changes that would potentially reduce the frequency of medication errors resulting in patient harm. Assembly Bill 1286 is a culmination of a yearlong effort undertaken by an ad hoc committee specifically focused on evaluating medication errors, working conditions, and the intersection of the two. As part of the Committee’s process, members heard from experts in the field, learned about authorities in other jurisdictions, and gained an understanding about findings and activities under way at the national level. It is incumbent upon the Board to act now on these findings to promote patient care.
As a compliment to the efforts of the ad hoc committee, the Board’s licensing committee also undertook a comprehensive review of the pharmacy technician licensing program with listening sessions, a dedicated summit, and several public discussions. The provisions related to pharmacy technicians reflect the outcomes of that effort, to assist pharmacists in performing authorized duties in a safe manner, allowing pharmacists to be redirected to perform more comprehensive patient care activities to promote patient safety. The goal of this provision is to ensure that information regarding medication errors are reported to the Board for review, but that the individual instances of medication error and kept private due to the sensitive nature of the information. The bill includes the following finding regarding the need for the limited disclosure in this bill:
To advance patient safety through medication error reduction, the primary purpose of the medication error reporting is to advance error prevention by analyzing individually and collectively medication error data that occurs in the community pharmacy setting to identify contributing factors and to broadly disseminate information on preventative measures and best practices for safe medication use, to advise regulators as part of its ongoing activities to monitor and improve the safety of medication use, and to advise policymakers to advance patient safety.
- Statements in opposition
The California Community Pharmacy Coalition is opposed to the bill stating that as currently written [it] will undermine patient access to pharmacy services and be detrimental to the health equity goals of California policymakers. Specifically they have concerns with:
- the staffing floor requirements in the bill being too rigid and unrealistic;
- the pharmacy to PT ratio; and
- that the medication error reporting is restricted to one organization.
In regards to the medication error reporting they write:
While CCPC is supportive of the goal of AB 1286 to reduce medication errors, we do not believe that requiring medication errors to be reported to a single organization – in this case the Institute for Safe Medication Practices (ISMP) - is the appropriate solution. Instead, we believe pharmacies should have the option to report this information more broadly to any patient safety organization (PSOs).
They also do not want the board to have any access to these medication error reports.
SUPPORT
California State Board of Pharmacy (sponsors)
California Labor Federation, AFL-CIO
California Pharmacists Association
United Food and Commercial Workers, Western States Council
OPPOSITION
California Community Pharmacy Coalition
RELATED LEGISLATION
Pending Legislation: None known.
Prior Legislation: None Known.
PRIOR VOTES
Senate Business, Professions and Economic Development Committee (Ayes 8, Noes 3)
Assembly Floor (Ayes 57, Noes 10)
Assembly Appropriations Committee (Ayes 12, Noes 2)
Assembly Business and Professions Committee (Ayes 11, Noes 1)
**************
The amendments may also include technical, nonsubstantive changes recommended by the Office of Legislative Counsel. ↑
SENATE COMMITTEE ON
BUSINESS, PROFESSIONS AND ECONOMIC DEVELOPMENT
Senator Richard Roth, Chair
2023 - 2024 Regular
Bill No: Hearing Date: July 3, 2023
Author: | |||
Version: |
| ||
Urgency: | Fiscal: | ||
Consultant: | |||
Subject:
SUMMARY:
Provides the Board of Pharmacy (Board) with cease and desist authority for specified conditions present in a pharmacy, updates the authority for pharmacy technicians to undertake certain tasks according to qualification and supervision requirements, requires certain medication error reporting, and authorizes pharmacy closure by a pharmacist if certain circumstances exist.
NOTE:
Double-referral to the Senate Committee on Judiciary, second.
Existing State Law:
- Establishes the Board in the Department of Consumer Affairs to administer and enforce the Pharmacy Law. (Business and Professions Code (BPC) § 4001 (a))
- Defines “pharmacist” as a natural person who has a license issued by the Board of Pharmacy who is entitled to practice pharmacy within or outside of a licensed pharmacy, as authorized by the Pharmacy Law. (BPC § 4036)
- Defines “pharmacist-in-charge” as a pharmacist proposed by a pharmacy and approved by the Board of Pharmacy as the supervisor or manager responsible for ensuring the pharmacy’s compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. (BPC § 4036.5)
- Authorizes a pharmacist to perform skin puncture in the course of performing routine patient assessment procedures or in the course of performing any authorized procedure. Defines, “routine patient assessment procedures” to mean: (a) procedures that a patient could, with or without a prescription, perform for himself or herself, or (b) clinical laboratory tests that are classified as waived pursuant to the federal Clinical Laboratory Improvement Amendments of 1988 (42 U.S.C. Sec. 263a) (CLIA), as specified. A pharmacist performing these functions shall report the results obtained from a test to the patient and any physician designated by the patient. Any pharmacist who performs the service authorized by this section shall not be in violation of Section 2052. (BPC § 4052.4)
- Establishes that anyone may perform a waived test in a licensed laboratory. (BPC § 1241)
- Authorizes a pharmacist to independently initiate and administer COVID-19 vaccines approved or authorized by the FDA, as specified. (BCP § 4052.8 (a))
- Defines a pharmacy technician (PT) as an individual who assists a pharmacist in a pharmacy in the performance of his or her related duties, which shall include packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist. Clarifies that a PT can only perform the above tasks with a pharmacist on duty. Prohibits a PT from performing any act requiring the exercise of professional judgment by a pharmacist. (BPC §§ 4038, 4115 (a-c))
- Requires the Board to adopt regulations to specify tasks that a PT may perform under the supervision of a pharmacist. Provides that any pharmacy that employs a PT shall do so in conformity with the regulations adopted by the Board.
(BPC § 4115 (d)) - Provides that no person shall act as a PT without first being licensed by the Board. (BPC § 4115 (e))
- Establishes that a pharmacy with only one pharmacist shall have no more than one PT (1:1). Establishes that any additional pharmacists shall oversee no more than two PTs, except if those PTs are performing specified clerical functions. Establishes that this ratio applies to all practice settings except for an inpatient of a health facility, a patient of a home health agency, an inmate of a correctional facility, or for a person receiving treatment through specified state services. (BPC § 4115 (f)(1))
- Authorizes pharmacists and pharmacies to perform, under specified conditions, particular tests that are classified as waived under CLIA and makes conforming changes and requires a pharmacy and a pharmacist-in-charge to maintain documents related to testing and compliance. (BPC §§ 1206, 1209, 4119.10)
- Authorizes the Board to adopt regulations establishing the ratio of PTs to pharmacists for an inpatient of a health facility or a patient of a home health agency. (BPC § 4115 (f)(2))
- Authorizes a pharmacist scheduled to supervise a second PT to refuse the duty if he or she determines that the additional PT would interfere with the responsibilities of the pharmacist. (BPC § 4115(f)(3))
- Requires the Board to establish regulations to permit the temporary absence of a pharmacist for breaks and lunch periods without closing the pharmacy.
(BPC § 4115 (g)) - Establishes that the pharmacist on duty is directly responsible for the conduct of a PT that he or she supervises. (BPC § 4115 (h))
- Specifies that a “chain community pharmacy” means a chain of 75 or more stores in California under the same ownership, and an “independent community pharmacy” means a pharmacy owned by a person or entity who owns no more than four pharmacies in California. (BPC § 4001 (c))
- Prohibits a community pharmacy from requiring a pharmacist to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless another employee, as specified, is made available to assist the pharmacist at all times. (BPC § 4113.5)
- Prohibits a chain community pharmacy from establishing a quota to measure or evaluate a pharmacist or pharmacy technician’s performance of duties, prohibits a chain community pharmacy from communicating the existence of quotas to employees or those it contracts with, and authorizes the Board of Pharmacy to take enforcement action against a community pharmacy that establishes a quota related to a pharmacist or pharmacy technician duties, unless by clear and convincing evidence the community pharmacy can demonstrate the violation was contrary to its policy.(BPC § 4113.7)
- Provides that unprofessional conduct includes, but is not limited to: procurement of a license by fraud or misrepresentation; incompetence; gross negligence; the clearly excessive furnishing of controlled substances, as specified; the clearly excessive furnishing of controlled substances, as specified, among other things. (BPC § 4301)
- Defines “CLIA” as the federal Clinical Laboratory Improvement Amendments of 1988 (United States Code, title 42, § 263a; Public Law 100-578) and the regulations adopted by the federal Health Care Financing Administration (HFCA) that are effective on January 1, 1994, or later when adopted by the CDPH after being deemed equivalent to or more stringent than California laws or regulations, as specified. (BPC § 1202.5(a); BPC § 1208(b))
- Defines “clinical laboratory test or examination” as the detection, identification, measurement, evaluation, correlation, monitoring, and reporting of any particular analyte, entity, or substance within a biological specimen for the purpose of obtaining scientific data which may be used as an aid to ascertain the presence, progress, and source of a disease or physiological condition in a human being, or used as an aid in the prevention, prognosis, monitoring, or treatment of a physiological or pathological condition in a human being, or for the performance of nondiagnostic tests for assessing the health of an individual. (BPC § 1206(a)(5))
- Defines “clinical laboratory” as any place used or any establishment or institution organized or operated for the performance of clinical laboratory tests or examinations or the practical application of the clinical laboratory sciences. (BPC § 1206(a)(8))
- Requires every clinical laboratory to operate under the overall operation and administration of a laboratory director. (BPC § 1206.5(a), 1206.5(b), 1206.5(c))
This bill:
- Authorizes the pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist’s ability to practice competently and safely. Specifies that, if the pharmacist-in-charge is not available, a pharmacist on duty may adjust staffing according to workload if needed.
- Requires the pharmacist-in-charge or pharmacist on duty to immediately notify store management of any conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. States store management will take immediate and reasonable steps to address and resolve the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. States that if conditions are not resolved within 24 hours, the pharmacist-in-charge or pharmacists on duty will ensure the board is timely notified.
- Specifies that conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff may include, but are not limited to, any of the following:
- Workplace safety and health hazards, including those contained in Division 5 the Labor Code.
- Sustained temperatures that could impact ambient temperature drug stability according to manufacturer data on acceptable drug storage conditions.
- Vermin infestation that poses a risk to the safety or efficacy of medicine.
- Authorizes the Board Executive Officer (EO), if they have a reasonable belief that conditions within a pharmacy exist that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, to issue an order to the pharmacy to immediately cease and desist all or a portion of the pharmacy’s operations which shall remain in effect until either the EO determines the condition or conditions that presented an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff have been abated during regular pharmacy business hours or for no more than 30 days, whichever is shorter. Specifies that failure to comply with a cease and desist order is unprofessional conduct. Clarifies that this authority does not prohibit a permit holder from closing a pharmacy to mitigate against a perceived immediate risk or death, illness, or irreparable harm to patients, personnel, or pharmacy staff.
- Requires a community pharmacy, defined as any pharmacy that dispenses medication to an outpatient, to report all medication errors to a Board-approved entity no later than 14 days following the date of discovery of the error, subject to various recordkeeping requirements. Clarifies that a medication error report shall not be subject to discipline or other enforcement action based solely on the report but if the Board receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the Board.
- Authorizes the pharmacist on duty to close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under this chapter in a safe manner without fear of retaliation. Requires a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. Prohibits the Board from taking action against a pharmacy for a violation if certain conditions exist or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs. States where staffing of pharmacist hours within a chain community pharmacy does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
- Authorizes a PT, in addition to their other authorized tasks, to, pharmacy technician, under the direct supervision and control of a pharmacist, administer influenza and COVID-19 vaccines via injection or intranasally, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions if the pharmacist-in-charge of the pharmacy has deemed the PT competent to perform the tasks and documents that; if another PT can assist the pharmacist by performing the existing tasks PTs are authorized to perform; if the PT is certified; if the PT has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technician’s injection technique and; if the PT is certified in basic life support.
- Requires a consulting pharmacist at a surgical clinic licensed by the Board to complete a Surgical Clinic Self-Assessment Form to assess the clinic’s compliance with current laws and regulations and include information on compounding practices and requires the professional director of the clinic and consulting pharmacist to certify on the final page of the form that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the Board.
- Adds the following to the list of violations that constitute unprofessional conduct:
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacist’s ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations.
- Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
- Authorizes the Board to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the Board, not to exceed $5,000 for each occurrence pursuant to a citation issued by the board.
FISCAL EFFECT:
This bill is keyed fiscal by Legislative Counsel. According to the Assembly Committee on Appropriations, The Board estimates minor and absorbable costs for activities that will include education on the new requirements, updating the self-assessment forms where appropriate, development of a self-assessment form for surgical clinics, and securing changes to renewal forms for surgical clinics.
COMMENTS:
- Purpose. The California State Board of Pharmacy is the Sponsor of this bill. According to the Author, “Community chain pharmacies and the pharmacists who work for them are instrumental in delivering care to Californians. However, recent news reports have highlighted alarming medication errors in this setting—including errors that have led to death. The root cause of medication errors in the community chain setting can be tied to pharmacy working conditions, like insufficient staffing, unsanitary conditions, or lack of autonomy to make clinical decisions in the best interest of the patient. Unfortunately, there is no requirement under current law for pharmacies to track medication errors or to consider the pharmacy working conditions that lead to medication errors. To address the root cause of medication errors and major faults in Pharmacy Law, AB 1286 will establish a first in the nation mandatory reporting of medication errors to allow for robust evaluation of the causes of medication errors. It also gives licensed pharmacy staff autonomy over their working conditions so they can provide better patient care and services for Californians.”
The Author states that this bill “is a comprehensive multifaceted approach to promote safe pharmacist care for patients. The measure contains common sense provisions such as allowing staffing decisions to be made at the pharmacy level by pharmacists responsible for operational compliance as well as a mechanism to close a pharmacy if conditions are unsafe to provide appropriate patient care. The measure also establishes a first in the nation, mandatory reporting of medication errors.”
According to the Author, California law prohibits most categories of healthcare providers from being employed by corporations. However, pharmacists and pharmacy technicians are two of the few licensed healthcare providers that can be employed directly by large corporations. Additionally, there is no statewide requirement that pharmacists working for these corporations report medication errors.”
The Author states that “Following national media reports on pharmacy working conditions and medication errors, and in response to issues identified as part of the Board’s sunset review, the Board conducted a survey of community pharmacists. Results of a Board survey of licensed pharmacists highlighted significant challenges facing pharmacists working in community pharmacies, most notably in community chain pharmacies. As examples:
- 78% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide adequate screening prior to the administration of immunizations.
- 83% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide appropriate patient consultation.
- 91% of pharmacists working in community chain pharmacies indicated they did not believe staffing in their primary worksite is appropriate to ensure adequate patient care.
- 90% of pharmacists working in community chain pharmacies indicated that their primary worksite has a work queue that monitors the wait time for a prescription.
In response to these extremely troubling survey findings, the Board established an ad hoc committee to evaluate the issue of medication errors, workforce challenges, and the intersection between the two. AB 1286 is a result of the years long effort of the committee and reflects the knowledge gained from experts in the field and stakeholders.”
- Background. The Board regulates the practice of pharmacies, pharmacists, interns, PTs, and others, including those who are involved with the wholesale or manufacturer of drugs and medical devices, but not required to hold a pharmacist license. The Board also regulates all types of firms that distribute prescription drugs and devices in California, including community pharmacies and those located in hospitals, clinics, home and community support services facilities, and out-of-state mail order pharmacies that fill prescriptions and deliver them in California. In Fiscal Year 2019/2020, there were approximately 143,242 licensees under the Board’s jurisdiction.
According to the findings and declarations in current law, pharmacists are health care professionals whose training and experience play a vital role in protecting public health. Pharmacists are legally and ethically bound to advise their patients, physicians, and other health practitioners on the selection, dosages, interactions, and side effects of medications as well as monitor the health and progress of those patients to ensure that they are using their medications safely and effectively. According to BPC § 4001.1, the highest priority for the regulation of pharmacists is protection of the public.
Depending on their setting, pharmacists’ scope of practice can diminish or expand. For example, pharmacists in any setting may administer the following tests and medications: toxicology, drug-therapy, and disease management and protection; over the counter tests for blood glucose and hemoglobin levels; hormonal contraceptives; prescription medications that do not require a prescription for travel purposes; nicotine replacement products; HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP); routine and the COVID-19 vaccination; skin puncture if the test is CLIA-waived and a person could perform the test at home themselves; certain dialysis drugs; and opioid antigen injections.
However, other tests, medications, and procedures require pharmacists to practice: in a health care facility; in a licensed home health agency; in a licensed correctional clinic; in a licensed clinic in which there is physician oversight; with a provider who contracts with a licensed health care service plan with regard to the care or services provided to the enrollees of that health care service plan; or with a physician, in accordance with the policies, procedures, or protocols of that facility, agency, clinic, service plan, or physician. Settings generally offer varying degrees of supervision by medical professionals depending on the setting. In these settings, pharmacists may: complete drug-therapy patient assessments (such as taking temperature, pulse, and respiration); order drug-therapy related laboratory tests; administer drugs and biologics by injection; initiate and adjust drug regime by patient provider.
In a recent effort to support pharmacists in specific work environments, SB 1442 (Wiener, Chapter 569, Statutes of 2018) prohibited a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless another employee is made available to assist the pharmacist at all times.
Most health professions require that licensees of the profession(s) in question are owners, shareholders, or otherwise have authority over other licensees within a company setting. For example, the Medical Board of California explains that this “policy expressed in Business and Professions Code section 2400 against the corporate practice of medicine is intended to prevent unlicensed persons from interfering with or influencing the physician’s professional judgment.” The theory is that licensed members of a profession have just as much incentive to choose ethical integrity over profit as their employees, as all are subject to the same licensing rules and regulations. Chiropractors, dentists, and speech language pathologists are among the other professions that have a similar policy. Existing law does not prevent unlicensed persons from being shareholders or corporate owners over pharmacists or pharmacy technicians.
BOP Current Action. Based on the workplace board survey described above, BOP says the following regarding this bill: “Assembly Bill 1286 is a culmination of a yearlong effort undertaken by an ad hoc committee specifically focused on evaluating medication errors, working conditions, and the intersection of the two. This committee was formed after the Board considered survey results from its own workforce survey that included some startling findings including 83% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide appropriate patient consultation, while 32% of pharmacists working in community independent pharmacies indicated same. As part of the Committee’s process, members heard from experts in the field, learned about authorities in other jurisdictions, and gained an understanding about findings and activities under way at the national level. It is incumbent upon the Board to act now on these findings to promote patient care.”
- Arguments in Support. The California State Board of Pharmacy writes in support and sponsorship: “As a consumer protection agency, the Board is charged with regulating the practice of pharmacy. Assembly Bill 1286 will address current risks to patient safety through a multi-faceted approach addressing medication errors and known contributions to such errors. These issues must be addressed to prevent future harm. The Board acknowledges that the California Retailers Association is opposed to the measure. The Board notes that consumer protection cannot be compromised. As the statute states, “whenever the protection of the public is inconsistent with other interests sought to be promoted, the protection of the public shall be paramount.”
According to the Board, “Assembly Bill 1286 is a culmination of a yearlong effort undertaken by an ad hoc committee specifically focused on evaluating medication errors, working conditions, and the intersection of the two. This committee was formed after the Board considered survey results from its own workforce survey that included some startling findings including 83% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide appropriate patient consultation, while 32% of pharmacists working in community independent pharmacies indicated same. As part of the Committee’s process, members heard from experts in the field, learned about authorities in other jurisdictions, and gained an understanding about findings and activities under way at the national level. It is incumbent upon the Board to act now on these findings to promote patient care.”
The California Alliance for Retired Americans writes in support: “Pharmacists are professionals trained to act as a backstop against prescribing errors. They are in a unique position to detect the risks of interactions between prescribed and non-prescribed medications. Pharmacists can also note adverse reactions and medication complications that prescribers may have missed.”
The California Pharmacists Association states that it “supports safe working conditions for its members and patients, as it has a positive impact on better and safer care being provided. Patient safety is paramount to CPhA and is cited throughout our policies. In 2021, CPhA co-sponsored SB 362 (Newman) (chapter 334, 2021) which prohibited the practice of imposing business quotas intended to increase corporate profit margins on the backs of pharmacists and pharmacy technicians. Prior to SB 362, pharmacists who work for large corporate-owned chain pharmacies were routinely forced to meet corporate benchmarks based on business metrics, which, at times, conflicted to the ethical standards, education, and training of pharmacists. In 2018, SB 1442 (Wiener) was signed into law (chapter 569). The bill prohibited pharmacies from requiring pharmacist employees to engage in the practice of pharmacy unless another employee is made available to assist the pharmacist(s). Based on feedback from our members, the law has not ensured that pharmacists have appropriate staffing assistance in the pharmacy.”
The California Labor Federation, AFL-CIO writes in support: “AB 1286 will address this crisis by authorizing a pharmacist-in-charge to make critically important staffing decisions in a pharmacy, authorizing pharmacy technicians with specified training to perform certain urgent tasks, such as administering vaccines and epinephrine, and requiring a community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services, among other reforms.”
The Consumer Protection Policy Center at the USD School of Law notes that The Board cis harged by law with protecting patients who need prescription medicines to stay alive, heal, and reduce suffering is telling this Legislature Californians are broadly and deeply at risk of death and needless anguish. The cause? Nothing more than publicly traded chain pharmacies placing short-term profits over the lives of California families.”
The United Food and Commercial Workers Western States Council (UFCW), believes that the language in this bill “is the most important part of the bill. Our licensee members have literally wept to us in meetings regarding their simple inability to perform their jobs safely. Because of the chain pharmacy's elevation of profits over patient safety, our vastly overworked members (again, see the Board’s survey) worry constantly about making possibly lethal errors, destroying lives and ruining their careers. This is all because of inadequate staffing.”
- Arguments in Opposition. The California Community Pharmacy Coalition is opposed to this bill and highlights various provisions as problematic:
- Pharmacist-in-Charge authority to close a pharmacy will have a detrimental impact on patient access to their medications. AB 1286 gives a pharmacist the authority to close a pharmacy if that pharmacist feels, in their opinion, that staffing is insufficient to fill prescriptions or provide other health care services to patients. In addition, the bill will authorize the immediate closure of a pharmacy by a pharmacist if they believe there is an undefined “immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.” This language, even as amended on May 31, 2023, is incredibly ambiguous and arbitrary and does not take into consideration the subjectivity of individual pharmacists or the implications of a pharmacy closure. The bill, if passed, will result in unplanned and last-minute pharmacy closures across the state, which will be hugely detrimental to Californians who rely on their community pharmacies for medications, testing, vaccines and other critical healthcare services. What if the pharmacy is located in a rural area and is the only place where a patient can access emergency medications? If that pharmacy closes, that patient will be forced to go without their medication and potentially rely on the Emergency Department for care, which will cause a significant financial strain on our healthcare system.
- Staffing floor requirements are too rigid and unrealistic. CCPC is concerned that AB 1286’s requirement to establish a rigid staffing floor will have implications for patient access to pharmacy services. The bill requires a technician or clerk to be on-site at the pharmacy at all times. Pharmacies determine staffing needs based on medication dispensing volume. If volume is low in stores, sometimes a pharmacist might work on their own during less busy hours. Previous legislation – SB 1442 (Chapter 569, 2018) requires that a person be available in the retail store at all times to assist the pharmacist when needed, this is already in statue.
- The pharmacist to pharmacy technician ratio should be revised. California has the most stringent pharmacist to pharmacy technician ratio in the nation with a required 1:1, yet we are the largest state in the nation. 24 other states have an unlimited ratio. Others have no less than a 1:3 ratio. This strict requirement creates the situations that the proponents of AB 1286 want to avoid by restricting a pharmacy from employing any more than one pharmacy technician for every pharmacist. With this restrictive ratio, there is no cushion if a pharmacy technician calls in sick or needs to leave early for emergency reasons. A pharmacist/pharmacy has no flexibility to create a staffing environment that works best for patients’ medication needs.
- Medication Error reporting should not be restricted to one organization. While CCPC is supportive of the goal of AB 1286 to reduce medication errors, we do not believe that requiring medication errors to be reported to a single organization – in this case the Institute for Safe Medication Practices (ISMP) - is the appropriate solution. Instead, we believe pharmacies should have the option to report this information more broadly to any patient safety organization (PSOs). AB 1286 (Haney) as currently written, will have a detrimental impact on patient access to pharmacy services. Instead, the bill should be modified to expand the pharmacist to pharmacy technician ratio, have the Board of Pharmacy work collaboratively with pharmacists and pharmacy companies to develop plans and perimeters to address situations where a pharmacy might need to limit services or close during emergencies and lastly to address medication errors through a more reasonable approach to reporting.”
- Policy Questions, Concerns, and Suggested Amendments.
Reference to Labor Code violations. The measure currently includes cross reference to Labor Code sections in provisions outlining the conditions that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. In order to provide clarity as to which workplace safety and health hazards are relevant and may be enforceable in the pharmacy space, the bill should be amended to strike reference to the Labor Code.
On page 6, in lines 27-29, strike “including those contained in Division 5 (commencing with Section 6300) of the Labor Code” and replace with “that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff”
Workplace safety and health hazards, including those contained in Division 5 (commencing with Section 6300) of the Labor Code. that present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff
Pharmacist Opinion. Pharmacists are provided the ability, like all licensed health care providers, to make decisions aimed at promoting the health and well-being of patients. Language in this bill provides a pharmacist, through vague reference to their opinion (a term not typically included in a licensing context given that professional judgment is more the norm) on staffing matters, the authority to close only a chain community pharmacy if, “in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under this chapter in a safe manner without fear of retaliation.” Pharmacists may face licensure restrictions or enforcement from the Board based on actions that do not conform to the standard of care but are usually not retaliated against by a licensing entity and the closure of a pharmacy, impacting patient care, should be left to clearly defined circumstances described throughout the measure related to conditions that immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. An opinion related to staffing is not defined in the bill, does not reference clinical or professional judgment, and is not something that is easily enforced, thus potentially creating significant challenges in the Board’s ability to implement and apply these provisions. In order to provide clarity and eliminate vagueness, the bill should be amended to strike the language contained in Section 3 of the bill, specifically the amendments that add (e) to BPC Section 4113.5.
On page 10, strike lines 9-13 inclusive.
(e) The pharmacist on duty may close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services for which a license is required under this chapter in a safe manner without fear of retaliation.
Drafting Challenges and Confusing Terms. In addition to the changes noted above, the measure may benefit from additional clarity and restructuring. Specifically, provisions related to activity in a “chain community pharmacy” are added into existing law governing community pharmacies. In order to be clear about provisions that only apply to this type of pharmacy, the Author may wish to consider adding a new section specific to the requirements outlined for chain community pharmacies about staffing, similar to the way that language related to quotas in chain community pharmacies was added to an entirely new section of Pharmacy Law through SB 362 (Newman, Chapter 334, Statutes of 2021).
It is further unclear why the bill would require a PT, a licensed individual, who under the bill would have to meet specified requirements to perform certain tasks, to only be authorized to do those in practice if a pharmacist-in-charge deems them competent. The PT license conferred by the Board and limited scope to perform certain tasks should outline what they can and cannot do. If they are licensed and meet the requirements, why would a pharmacist deem them competent? How is this enforceable? What disparity may exist in the ability of certain PTs to advance in their career if all are licensed and only some in some settings, according to the determination of a person, and not based on standards, are deemed “competent”? In order to ensure that the Pharmacy Law remains clear and PTs perform tasks for which they are licensed, the Author may wish to strike reference in Section 4 of the that allows a pharmacist-in-charge to deem a PT competent to perform the additional tasks.
What is tend to subvert? It is not clear what language in Section 7 of the bill, amendments to BPC 4301 to add new unprofessional conduct provisions, specifying “tend to subvert” means or intends to capture. In order to provide clear unprofessional conduct violations, the Author may wish to strike this vague term.
Who is a permitholder? This bill specifically clarifies that even with the Board’s cease and desist authority for conditions that present an immediate risk of death, illness, or irreparable harm, nothing shall prevent a “permitholder from closing a pharmacy to mitigate against a perceived immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff.” It is not clear who or what a permitholder is, as reference throughout Pharmacy Law is to a licensee, or even more specifically, the exact licensee authorized to do something. In order to ensure conformity with the rest of the Law, the Author may wish to strike this section or replace permitholder with licensee.
SUPPORT AND OPPOSITION:
Support:
California State Board of Pharmacy (Sponsor)
California Alliance for Retired Americans
California Labor Federation
Consumer Protection Policy Center
United Food and Commercial Workers, Western States Council
Opposition:
California Community Pharmacy Coalition
-- END --
ASSEMBLY THIRD READING
ATR Bill Id:AB 1286
Author:(Haney)
As Amended Ver:May 31, 2023
Majority vote
SUMMARY
Authorizes a pharmacist-in-charge to make staffing decisions in a pharmacy and to close a pharmacy under conditions that present an immediate risk of death, illness, or irreparable harm; requires a chain community pharmacy to be staffed with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services, except as provided; authorizes pharmacy technicians with specified training to perform additional tasks, including administering influenza and COVID-19 vaccines and epinephrine and performing specimen collection for laboratory tests; requires community pharmacies to report medication errors; and requires consulting pharmacists to complete a Surgical Clinic Self-Assessment Form every other year, among other provisions.
Major Provisions
- Provides that the pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist's ability to practice competently and safely, or a pharmacist on duty if the pharmacist-in-charge is not available.
- Authorizes the pharmacist-in-charge to close a pharmacy under conditions that, based on the pharmacist-in-charge's professional judgment, present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff, and requires the pharmacist-in-charge to reopen the pharmacy immediately upon the abatement of the conditions.
- Authorizes the pharmacist on duty to close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services in a safe manner without fear of retaliation.
- Requires a chain community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services, except under reasonably unanticipated circumstances or when the pharmacist on duty waives the requirement, and requires scheduled closures for lunch time for all pharmacy staff to be established and publicly posted and included on the outgoing telephone message where staffing of pharmacist hours does not overlap sufficiently.
- Requires a community pharmacy to report all medication errors to an entity approved by the State Board of Pharmacy (BOP), no later than 14 days following the date of discovery of the error, and to maintain records demonstrating compliance with this requirement for three years and to make these records immediately available at the request of an inspector.
- Prohibits the BOP from taking disciplinary action solely based on a medication error report, unless it receives other information regarding the medication error.
- Authorizes a pharmacy technician to administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the certain conditions.
- Provides that a pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the above additional tasks, but that a second pharmacy technician is then available to perform standard tasks, notwithstanding the Pharmacy Law's 1:1 ratio.
- Requires the consulting pharmacist at a clinic to complete a Surgical Clinic Self-Assessment Form before July 1 of every odd-numbered year, as determined by the BOP, as a means to promote compliance through self-examination and education, and requires the consulting pharmacist at a clinic to certify compliance as part of their renewal process.
- Adds various actions or conduct to acts that constitute unprofessional conduct by licensees, subject to discipline by the BOP, including actions or conduct that subvert a pharmacist to comply with laws and regulations, or exercise professional judgment.
- Authorizes the BOP to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the BOP, not to exceed $5,000 for each occurrence pursuant to a citation issued by the BOP.
COMMENTS
Pharmacist-in-Charge Authority. Under the Pharmacy Law, pharmacists licensed by the BOP can be directly employed by retailers and other community pharmacies. This has remained the case despite increasing recognition of their professional training and authority to exercise a meaningful degree of clinical judgement, which has resulted in numerous scope expansions for the profession. However, each pharmacy must designate a "pharmacist-in-charge," subject to approval by the BOP. This pharmacist-in-charge is responsible for a pharmacy's compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would expand the autonomy of the pharmacist-in-charge to make certain staffing and pharmacy operations decisions that the pharmacist-in-charge believes to be in the best interest of personnel and patients. First, the bill would authorize the pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist's ability to practice competently and safely. This authority would be delegated to the pharmacist on duty if the pharmacist-in-charge is not available.
Second, this bill would authorize the pharmacist-in-charge to close the pharmacy under certain that, based on the pharmacist-in-charge's professional judgment, present an immediate risk of death, illness, or irreparable harm to patients, personnel, or pharmacy staff. The pharmacist-in-charge would subsequently be required to reopen the pharmacy as immediately upon the abatement of those conditions. The pharmacist on duty would additionally be allowed to close a chain community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services in a safe manner without fear of retaliation.
Pharmacy Staffing. Pharmacists working in chain community pharmacies, particularly those co-located with other retail and grocery stores, have historically complained that it is common for a pharmacist to be the only employee assigned to the pharmacy area. According to previously conducted surveys, 83% of pharmacists report being left alone during the workday for an average period of four hours. Within this population, the survey indicated that a high percentage of pharmacists stated that they do not have enough time to fulfill their professional functions to the extent that they believed necessary. These pharmacists have argued that instead of providing their core pharmacy services, much of their time is instead spent performing clerical tasks and performing non-pharmacy activities on behalf of the business.
Statute authorizes an unlicensed employee to provide purely clerical assistance to a pharmacist, and for a pharmacy technician licensed by the BOP to assist a pharmacist with a number of more sensitive pharmacy service activities. The Pharmacy Law imposes a strict cap on the number of pharmacy technicians who may be assigned to assist a pharmacist; a single pharmacist may be assisted by no more than a single pharmacy technician. Many community pharmacy owners believe that this restrictive law, referred to as the "pharmacist/pharmacy technician ratio," frequently results in inadequate staff support for pharmacists and an inability for some community pharmacies to adequately meet the demands of their patients. Several efforts to increase this ratio over the years have failed to pass.
In 2018, SB 1442 (Wiener), Chapter 569, was enacted to prohibit community pharmacies from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee is made available to assist the pharmacist at all times. An exception was included for situations where another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, and the pharmacy takes all reasonable action to make another employee available to assist the pharmacist.
Representatives of pharmacists who work in community pharmacies have complained that the 2018 legislation has not been effectively implemented due to deficiencies in the law. These organizations report that pharmacists are often still left alone without support staff in many cases where additional staff is needed. This bill would seek to rectify this issue by expressly requiring that a chain community pharmacy be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would additionally provide that where staffing of pharmacist hours does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
Pharmacy Technician Scope. Over the past several years, the BOP has voted to support the development of a legislative proposal to create a new mid-level practitioner in pharmacy settings. This proposed "advanced pharmacy technician" would be authorized to carry out certain duties that pose a relatively low risk of patient harm but may currently only be performed by pharmacists, allowing a pharmacist to spend more time engaged in patient care. While the BOP has formally pursued legislation to establish a new license category for advanced pharmacy technicians and enable these mid-level practitioners to serve in pharmacies, no legislative attempt has been successful to date.
During the COVID-19 pandemic, the Governor signed an executive order that created a new process for boards and the public to request waivers of requirements related to healing arts professional licensing through the Department of Consumer Affairs (DCA). Through this waiver process, the DCA issued multiple waivers of law to authorize various healing arts licensees to order and administer the COVID-19 vaccine. These waivers have extended to pharmacy technicians, as well as pharmacists and other healing arts professionals, consistent with the federal Public Readiness and Emergency Preparedness (PREP) Act. On August 4, 2021, the federal Health and Human Services Agency issued an amendment to the Public Readiness and Emergency Preparedness (PREP) Act to extend coverage to pharmacy technicians with proper training to administer seasonal flu vaccines to adults in addition to the COVID-19 vaccine.
This bill would authorize pharmacy technicians to administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for CLIA-waived tests, receive prescription transfers, and accept clarification on prescriptions. The pharmacist-in-charge must first deem the pharmacy technician competent to perform those tasks and documented that determination in writing. The pharmacy technicians would also be required to complete at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technician's injection technique. A pharmacy technician who qualifies to perform the additional tasks would then not count in the Pharmacy Law's 1:1 ratio, and another pharmacy technician would be required to assist with other tasks.
Surgical Clinic Self-Assessment Forms. The Pharmacy Law requires certain clinics, including surgical clinics, accredited outpatient settings, and certified ambulatory surgical centers to obtain a license from the BOP. These clinics are required to retain a consulting pharmacist to approve the clinic's policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist is required to visit the clinic regularly and at least quarterly. The consulting pharmacist is then required to certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of the Pharmacy Law. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate.
This bill would additionally require each consulting pharmacist for a clinic to complete a Surgical Clinic Self-Assessment Form, as determined by the BOP, as a means to promote compliance through self-examination and education. The self-assessment is intended to assess the clinic's compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the BOP and posted on its website. The professional director of the clinic and consulting pharmacist would be required to certify that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form would then be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the BOP or its designee, upon request. This process would be required before July 1 on each odd-numbered year and would be incorporated into the consulting pharmacist's renewal process, along with certification of compliance with quarterly inspection requirements.
Medication Errors. The BOP has listed medication error as the number one violation resulting in a citation in nearly every year within the last several years. According to the Journal of the American Medical Association, 46 percent of adults cannot understand the information listed on their prescription drug labels. Furthermore, the Institute of Medicine of the National Academies indicates that medication errors are among the most common medical errors, harming at least 1.5 million people annually.
This bill would seek to improve the state's understanding of the causes of medication errors by requiring community pharmacies to report all medication errors to an entity approved by the BOP. A community pharmacy would be required to submit the report no later than 14 days following the date of discovery of the error. Reports would be deemed confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. The BOP would not be allowed to subject a community pharmacy to discipline or other enforcement action based solely on the report; however, if the BOP receives other information regarding the medication error, that may serve as basis for discipline or other enforcement by the BOP.
Unprofessional Conduct. The BOP's Enforcement Unit regularly engages in investigations of licensees that may result in disciplinary action, as well as cases involving unlicensed activity. Over 12,100 investigations were completed from FY 2015/16 through FY 2018/19, with 1,335 referrals for formal discipline resulting in the revocation or surrender of 854 licenses and 462 licenses placed on probation. In addition, the BOP issued a total of 7,223 citations. On average, the BOP receives around 3,500 complaints per year. These complaints are then categorized into priorities based on the potential risk to public health and safety.
The Pharmacy Law requires the BOP to take action against any licensee who is guilty of unprofessional conduct. Statute provides that unprofessional conduct includes various specified acts and omissions, including incompetence, gross negligence, inappropriate furnishing of controlled substances, and other violations of law. Existing law specifies that engaging in any conduct that subverts or attempts to subvert an investigation of the BOP is unprofessional conduct. This bill would further add to the list of what constitutes unprofessional conduct, including actions or conduct that subvert the efforts of a pharmacist to comply with laws and regulations or exercise professional judgment.
According to the Author
"Community chain pharmacies and the pharmacists who work for them are instrumental in delivering care to Californians. However, recent news reports have highlighted alarming medication errors in this setting—including errors that have led to death. The root cause of medication errors in the community chain setting can be tied to pharmacy working conditions, like insufficient staffing, unsanitary conditions, or lack of autonomy to make clinical decisions in the best interest of the patient. Unfortunately, there is no requirement under current law for pharmacies to track medication errors or to consider the pharmacy working conditions that lead to medication errors. To address the root cause of medication errors and major faults in Pharmacy Law, AB 1286 will establish a first in the nation mandatory reporting of medication errors to allow for robust evaluation of the causes of medication errors. It also gives licensed pharmacy staff autonomy over their working conditions so they can provide better patient care and services for Californians."
Arguments in Support
The United Food and Commercial Workers Western States Council (UFCW) supports this bill. According to UFCW: "The Board charged by law with protecting patients who need prescription medicines to stay alive, heal, and reduce suffering is telling this Legislature Californians are broadly and deeply at-risk of death and needless anguish. The cause? Nothing more than publicly traded chain pharmacies placing short-term profits over the lives of California families. This bill is one of the most important public health bills pending this year. It is based on careful study, is proportional, and, according to the expert regulator, urgently needed."
The California State Board of Pharmacy (BOP) is sponsor of this bill. The BOP writes: "Assembly Bill 1286 is a culmination of a yearlong effort undertaken by an ad hoc committee specifically focused on evaluating medication errors, working conditions, and the intersection of the two. This committee was formed after the Board considered survey results from its own workforce survey that included some startling findings including 83% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide appropriate patient consultation, while 32% of pharmacists working in community independent pharmacies indicated same. As part of the Committee's process, members heard from experts in the field, learned about authorities in other jurisdictions, and gained an understanding about findings and activities under way at the national level. It is incumbent upon the Board to act now on these findings to promote patient care."
Arguments in Opposition
The California Community Pharmacy Coalition (CCPC), a project of the California Retailers Association, opposes this bill. In regards to the bill's minimum staffing requirements, the CPPC writes: "Although CCPC acknowledges the benefits of having additional non-pharmacist staff in the pharmacy, there are often unforeseen circumstances, out of the pharmacy's control, that make this impossible. For example, if there is only one technician working in the pharmacy and that technician calls in sick or is unable to make it to work on any given day, the pharmacy would have to close. We believe this is antithetical to the Board's role of consumer protection because pharmacy closures will result in reduced access to critical medications for consumers." In regards to the bill's provisions authorizing a pharmacist-in-charge to close a pharmacy, the CPPC argues: "The bill, if passed, will result in unplanned and last minute pharmacy closures across the state, which will be hugely detrimental to Californians who rely on their community pharmacies for medications, testing, vaccines and other critical healthcare services. What if the pharmacy is located in a rural area and is the only place where a patient can access an emergency medication? If that pharmacy closes, that patient will be forced to go without their medication and potentially rely on the Emergency Department for care, which will cause a significant financial strain on our healthcare system."
FISCAL COMMENTS
According to the Assembly Appropriations Committee, minor and absorbable costs to the BOP for activities that will include education on the new requirements, updating the self-assessment forms where appropriate, development of a self-assessment form for surgical clinics, and securing changes to renewal forms for surgical clinics.
VOTES
ASM BUSINESS AND PROFESSIONS: 11-1-6
YES: Berman, Bonta, Gipson, Grayson, Irwin, Jackson, Lee, Lowenthal, McKinnor, Stephanie Nguyen, Ting
NO: Dixon
ABS, ABST OR NV: Flora, Alanis, Alvarez, Chen, McCarty, Joe Patterson
ASM APPROPRIATIONS: 12-2-2
YES: Holden, Bryan, Calderon, Wendy Carrillo, Mike Fong, Hart, Lowenthal, Papan, Pellerin, Robert Rivas, Weber, Wilson
NO: Megan Dahle, Dixon
ABS, ABST OR NV: Mathis, Sanchez
UPDATED
VERSION: May 31, 2023
CONSULTANT: Robert Sumner / B. & P. / (916) 319-3301 FN: 0001058
ASSEMBLY THIRD READING
ATR Bill Id:AB 1286
Author:(Haney)
As Amended Ver:April 19, 2023
Majority vote
SUMMARY
Authorizes a pharmacist-in-charge to make staffing decisions in a pharmacy and to close a pharmacy under conditions that present an immediate risk to the health and safety; requires a community pharmacy to be staffed with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services, except as provided; authorizes pharmacy technicians with specified training to perform additional tasks, including administering influenza and COVID-19 vaccines and epinephrine and performing specimen collection for laboratory tests; requires community pharmacies to report medication errors; and requires consulting pharmacists to complete a Surgical Clinic Self-Assessment Form every other year, among other provisions.
Major Provisions
- Provides that the pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist's ability to practice competently and safely, or a pharmacist on duty if the pharmacist-in-charge is not available.
- Authorizes the pharmacist-in-charge to close a pharmacy under conditions that, based on the pharmacist-in-charge's professional judgment, present an immediate risk to the health and safety of patients, personnel, or pharmacy staff, or a pharmacist on duty if the pharmacist-in-charge is not available, and requires the pharmacist-in-charge or pharmacist on duty to reopen the pharmacy as soon as reasonably possible upon the abatement of the conditions.
- Authorizes the pharmacist on duty to close a pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services in a safe manner without fear of retaliation.
- Requires a community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services, except under reasonably unanticipated circumstances or when the pharmacist on duty waives the requirement, and requires scheduled closures for lunch time for all pharmacy staff to be established and publicly posted and included on the outgoing telephone message where staffing of pharmacist hours does not overlap sufficiently.
- Requires a community pharmacy to report all medication errors to an entity approved by the State Board of Pharmacy (BOP), no later than 14 days following the date of discovery of the error, and to maintain records demonstrating compliance with this requirement for three years and to make these records immediately available at the request of an inspector.
- Prohibits the BOP from taking disciplinary action solely based on a medication error report, unless it receives other information regarding the medication error.
- Defines "community pharmacy" as including any pharmacy that dispenses medication to an outpatient.
- Authorizes a pharmacy technician to administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive prescription transfers, and accept clarification on prescriptions under the certain conditions.
- Provides that a pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the above additional tasks, but that a second pharmacy technician is then available to perform standard tasks, notwithstanding the Pharmacy Law's 1:1 ratio.
- Requires the consulting pharmacist at a clinic to complete a Surgical Clinic Self-Assessment Form before July 1 of every odd-numbered year, as determined by the BOP, as a means to promote compliance through self-examination and education, and requires the consulting pharmacist at a clinic to certify compliance as part of their renewal process.
- Adds various actions or conduct to acts that constitute unprofessional conduct by licensees, subject to discipline by the BOP, including actions or conduct that subvert a pharmacist to comply with laws and regulations, or exercise professional judgment.
- Authorizes the BOP to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the BOP, not to exceed $5,000 for each occurrence pursuant to a citation issued by the BOP.
COMMENTS
Pharmacist-in-Charge Authority. Under the Pharmacy Law, pharmacists licensed by the BOP can be directly employed by retailers and other community pharmacies. This has remained the case despite increasing recognition of their professional training and authority to exercise a meaningful degree of clinical judgement, which has resulted in numerous scope expansions for the profession. However, each pharmacy must designate a "pharmacist-in-charge," subject to approval by the BOP. This pharmacist-in-charge is responsible for a pharmacy's compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would expand the autonomy of the pharmacist-in-charge to make certain staffing and pharmacy operations decisions that the pharmacist-in-charge believes to be in the best interest of personnel and patients. First, the bill would authorize the pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist's ability to practice competently and safely. This authority would be delegated to the pharmacist on duty if the pharmacist-in-charge is not available.
Second, this bill would authorize the pharmacist-in-charge to close the pharmacy under certain that, based on the pharmacist-in-charge's professional judgment, present an immediate risk to the health and safety of patients, personnel, or pharmacy staff. This authority would also be delegated to the pharmacist on duty if the pharmacist-in-charge is not available. The pharmacist-in-charge or pharmacist on duty would be required to reopen the pharmacy as soon as reasonably possible upon the abatement of those conditions. The pharmacist on duty would additionally be allowed to close a community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services in a safe manner without fear of retaliation.
Pharmacy Staffing. Pharmacists working in community pharmacies, particularly those co-located with other retail and grocery stores, have historically complained that it is common for a pharmacist to be the only employee assigned to the pharmacy area. According to previously conducted surveys, 83% of pharmacists report being left alone during the workday for an average period of four hours. Within this population, the survey indicated that a high percentage of pharmacists stated that they do not have enough time to fulfill their professional functions to the extent that they believed necessary. These pharmacists have argued that instead of providing their core pharmacy services, much of their time is instead spent performing clerical tasks and performing non-pharmacy activities on behalf of the business.
Statute authorizes an unlicensed employee to provide purely clerical assistance to a pharmacist, and for a pharmacy technician licensed by the BOP to assist a pharmacist with a number of more sensitive pharmacy service activities. The Pharmacy Law imposes a strict cap on the number of pharmacy technicians who may be assigned to assist a pharmacist; a single pharmacist may be assisted by no more than a single pharmacy technician. Many community pharmacy owners believe that this restrictive law, referred to as the "pharmacist/pharmacy technician ratio," frequently results in inadequate staff support for pharmacists and an inability for some community pharmacies to adequately meet the demands of their patients. Several efforts to increase this ratio over the years have failed to pass.
In 2018, SB 1442 (Wiener), Chapter 569, Statutes of 2018, was enacted to prohibit community pharmacies from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee is made available to assist the pharmacist at all times. An exception was included for situations where another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, and the pharmacy takes all reasonable action to make another employee available to assist the pharmacist.
Representatives of pharmacists who work in community pharmacies have complained that the 2018 legislation has not been effectively implemented due to deficiencies in the law. These organizations report that pharmacists are often still left alone without support staff in many cases where additional staff is needed. This bill would seek to rectify this issue by expressly requiring that a community pharmacy be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would additionally provide that where staffing of pharmacist hours does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
Pharmacy Technician Scope. Over the past several years, the BOP has voted to support the development of a legislative proposal to create a new mid-level practitioner in pharmacy settings. This proposed "advanced pharmacy technician" would be authorized to carry out certain duties that pose a relatively low risk of patient harm but may currently only be performed by pharmacists, allowing a pharmacist to spend more time engaged in patient care. While the BOP has formally pursued legislation to establish a new license category for advanced pharmacy technicians and enable these mid-level practitioners to serve in pharmacies, no legislative attempt has been successful to date.
During the COVID-19 pandemic, the Governor signed an executive order that created a new process for boards and the public to request waivers of requirements related to healing arts professional licensing through the Department of Consumer Affairs (DCA). Through this waiver process, the DCA issued multiple waivers of law to authorize various healing arts licensees to order and administer the COVID-19 vaccine. These waivers have extended to pharmacy technicians, as well as pharmacists and other healing arts professionals, consistent with the federal Public Readiness and Emergency Preparedness (PREP) Act. On August 4, 2021, the federal Health and Human Services Agency issued an amendment to the Public Readiness and Emergency Preparedness (PREP) Act to extend coverage to pharmacy technicians with proper training to administer seasonal flu vaccines to adults in addition to the COVID-19 vaccine.
This bill would authorize pharmacy technicians to administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for CLIA-waived tests, receive prescription transfers, and accept clarification on prescriptions. The pharmacist-in-charge must first deem the pharmacy technician competent to perform those tasks and documented that determination in writing. The pharmacy technicians would also be required to complete at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technician's injection technique. A pharmacy technician who qualifies to perform the additional tasks would then not count in the Pharmacy Law's 1:1 ratio, and another pharmacy technician would be required to assist with other tasks.
Surgical Clinic Self-Assessment Forms. The Pharmacy Law requires certain clinics, including surgical clinics, accredited outpatient settings, and certified ambulatory surgical centers to obtain a license from the BOP. These clinics are required to retain a consulting pharmacist to approve the clinic's policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist is required to visit the clinic regularly and at least quarterly. The consulting pharmacist is then required to certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of the Pharmacy Law. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate.
This bill would additionally require each consulting pharmacist for a clinic to complete a Surgical Clinic Self-Assessment Form, as determined by the BOP, as a means to promote compliance through self-examination and education. The self-assessment is intended to assess the clinic's compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the BOP and posted on its website. The professional director of the clinic and consulting pharmacist would be required to certify that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form would then be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the BOP or its designee, upon request. This process would be required before July 1 on each odd-numbered year and would be incorporated into the consulting pharmacist's renewal process, along with certification of compliance with quarterly inspection requirements.
Medication Errors. The BOP has listed medication error as the number one violation resulting in a citation in nearly every year within the last several years. According to the Journal of the American Medical Association, 46% of adults cannot understand the information listed on their prescription drug labels. Furthermore, the Institute of Medicine of the National Academies indicates that medication errors are among the most common medical errors, harming at least 1.5 million people annually.
This bill would seek to improve the state's understanding of the causes of medication errors by requiring community pharmacies to report all medication errors to an entity approved by the BOP. A community pharmacy would be required to submit the report no later than 14 days following the date of discovery of the error. Reports would be deemed confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. The BOP would not be allowed to subject a community pharmacy to discipline or other enforcement action based solely on the report; however, if the BOP receives other information regarding the medication error, that may serve as basis for discipline or other enforcement by the BOP.
Unprofessional Conduct. The BOP's Enforcement Unit regularly engages in investigations of licensees that may result in disciplinary action, as well as cases involving unlicensed activity. Over 12,100 investigations were completed from FY 2015/16 through FY 2018/19, with 1,335 referrals for formal discipline resulting in the revocation or surrender of 854 licenses and 462 licenses placed on probation. In addition, the BOP issued a total of 7,223 citations. On average, the BOP receives around 3,500 complaints per year. These complaints are then categorized into priorities based on the potential risk to public health and safety.
The Pharmacy Law requires the BOP to take action against any licensee who is guilty of unprofessional conduct. Statute provides that unprofessional conduct includes various specified acts and omissions, including incompetence, gross negligence, inappropriate furnishing of controlled substances, and other violations of law. Existing law specifies that engaging in any conduct that subverts or attempts to subvert an investigation of the BOP is unprofessional conduct. This bill would further add to the list of what constitutes unprofessional conduct, including actions or conduct that subvert the efforts of a pharmacist to comply with laws and regulations or exercise professional judgment.
According to the Author
"Community chain pharmacies and the pharmacists who work for them are instrumental in delivering care to Californians. However, recent news reports have highlighted alarming medication errors in this setting—including errors that have led to death. The root cause of medication errors in the community chain setting can be tied to pharmacy working conditions, like insufficient staffing, unsanitary conditions, or lack of autonomy to make clinical decisions in the best interest of the patient. Unfortunately, there is no requirement under current law for pharmacies to track medication errors or to consider the pharmacy working conditions that lead to medication errors. To address the root cause of medication errors and major faults in Pharmacy Law, AB 1286 will establish a first in the nation mandatory reporting of medication errors to allow for robust evaluation of the causes of medication errors. It also gives licensed pharmacy staff autonomy over their working conditions so they can provide better patient care and services for Californians."
Arguments in Support
The United Food and Commercial Workers Western States Council (UFCW) supports this bill. According to UFCW: "The Board charged by law with protecting patients who need prescription medicines to stay alive, heal, and reduce suffering is telling this Legislature Californians are broadly and deeply at-risk of death and needless anguish. The cause? Nothing more than publicly traded chain pharmacies placing short-term profits over the lives of California families. This bill is one of the most important public health bills pending this year. It is based on careful study, is proportional, and, according to the expert regulator, urgently needed."
The California State Board of Pharmacy (BOP) is sponsor of this bill. The BOP writes: "Assembly Bill 1286 is a culmination of a yearlong effort undertaken by an ad hoc committee specifically focused on evaluating medication errors, working conditions, and the intersection of the two. This committee was formed after the Board considered survey results from its own workforce survey that included some startling findings including 83% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide appropriate patient consultation, while 32% of pharmacists working in community independent pharmacies indicated same. As part of the Committee's process, members heard from experts in the field, learned about authorities in other jurisdictions, and gained an understanding about findings and activities under way at the national level. It is incumbent upon the Board to act now on these findings to promote patient care."
Arguments in Opposition
The California Community Pharmacy Coalition (CCPC), a project of the California Retailers Association, opposes this bill. In regards to the bill's minimum staffing requirements, the CPPC writes: "Although CCPC acknowledges the benefits of having additional non-pharmacist staff in the pharmacy, there are often unforeseen circumstances, out of the pharmacy's control, that make this impossible. For example, if there is only one technician working in the pharmacy and that technician calls in sick or is unable to make it to work on any given day, the pharmacy would have to close. We believe this is antithetical to the Board's role of consumer protection because pharmacy closures will result in reduced access to critical medications for consumers." In regards to the bill's provisions authorizing a pharmacist-in-charge to close a pharmacy, the CPPC argues: "The bill, if passed, will result in unplanned and last minute pharmacy closures across the state, which will be hugely detrimental to Californians who rely on their community pharmacies for medications, testing, vaccines and other critical healthcare services. What if the pharmacy is located in a rural area and is the only place where a patient can access an emergency medication? If that pharmacy closes, that patient will be forced to go without their medication and potentially rely on the Emergency Department for care, which will cause a significant financial strain on our healthcare system."
FISCAL COMMENTS
According to the Assembly Appropriations Committee on, minor and absorbable costs to the BOP for activities that will include education on the new requirements, updating the self-assessment forms where appropriate, development of a self-assessment form for surgical clinics, and securing changes to renewal forms for surgical clinics.
VOTES
ASM BUSINESS AND PROFESSIONS: 11-1-6
YES: Berman, Bonta, Gipson, Grayson, Irwin, Jackson, Lee, Lowenthal, McKinnor, Stephanie Nguyen, Ting
NO: Dixon
ABS, ABST OR NV: Flora, Alanis, Alvarez, Chen, McCarty, Joe Patterson
ASM APPROPRIATIONS: 12-2-2
YES: Holden, Bryan, Calderon, Wendy Carrillo, Mike Fong, Hart, Lowenthal, Papan, Pellerin, Robert Rivas, Weber, Wilson
NO: Megan Dahle, Dixon
ABS, ABST OR NV: Mathis, Sanchez
UPDATED
VERSION: April 19, 2023
CONSULTANT: Robert Sumner / B. & P. / (916) 319-3301 FN: 0000299
Date of Hearing: May 3, 2023
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Chris Holden, Chair
ABPCA Bill Id:AB 1286
Author:(Haney) – As Amended Ver:April 19, 2023
Policy Committee: | Business and Professions | Vote: | 11 - 1 |
|
| ||
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: No
SUMMARY:
This bill includes measures to improve working conditions and reduce medication errors in pharmacies.
Specifically, this bill authorizes a pharmacist-in-charge, or in some cases, a pharmacist on duty to: (1) make staffing decisions in a pharmacy to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist’s ability to practice competently and safely; or (2) close a pharmacy if workplace hazards, as specified, may create an unsafe environment for personnel or pharmacy staff. This bill also requires a community pharmacy to report all medication errors to an entity approved by the California State Board of Pharmacy (Board). The bill authorizes a pharmacy technician to administer influenza and COVID-19 vaccines, administer epinephrine, perform specimen collection for specified tests, receive prescription transfers, and accept clarification on prescriptions, under prescribed conditions. This bill requires a clinic’s consulting pharmacist to complete a surgical clinic self-assessment form every two years to confirm compliance with laws governing clinics.
The Board estimates minor and absorbable costs for activities that will include education on the new requirements, updating the self-assessment forms where appropriate, development of a self-assessment form for surgical clinics, and securing changes to renewal forms for surgical clinics.
COMMENTS:
- Purpose. The Board is the sponsor of this bill. According to the Board:
Assembly Bill 1286 is a culmination of a yearlong effort undertaken by an ad hoc committee specifically focused on evaluating medication errors, working conditions, and the intersection of the two. This committee was formed after the Board considered survey results from its own workforce survey that included some startling findings including 83% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide appropriate patient consultation, while 32% of pharmacists working in community independent pharmacies indicated same. As part of the committee’s process, members heard from experts in the field, learned about authorities in other jurisdictions, and gained an understanding about findings and activities under way at the national level. It is incumbent upon the Board to act now on these findings to promote patient care.
- Related Legislation.
- AB 1341 (Berman) authorizes pharmacists to continue furnishing COVID-19 oral therapeutics to patients who test positive for SARS-CoV-2, without a prior prescription. AB 1341 is pending on the Assembly Floor.
- SB 524 (Caballero) authorizes a pharmacist to furnish prescription medications that are furnished pursuant to the result from a test performed by the pharmacist that is used to guide diagnosis or clinical decision making. SB 524 is pending referral to the Senate floor.
- AB 1341 (Berman) authorizes pharmacists to continue furnishing COVID-19 oral therapeutics to patients who test positive for SARS-CoV-2, without a prior prescription. AB 1341 is pending on the Assembly Floor.
- Prior Legislation.
- AB 1064 (Fong), Chapter 655, Statutes of 2021, expanded the authority of a pharmacist to initiate and administer immunizations to include any vaccine approved or authorized by the FDA for persons three years of age and older.
- SB 1442 (Wiener), Chapter 569, Statutes of 2018, prohibited a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless another employee is made available to assist the pharmacist at all times.
- AB 1064 (Fong), Chapter 655, Statutes of 2021, expanded the authority of a pharmacist to initiate and administer immunizations to include any vaccine approved or authorized by the FDA for persons three years of age and older.
Analysis Prepared by: Allegra Kim / APPR. / (916) 319-2081
Date of Hearing: April 18, 2023
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Marc Berman, Chair
ABPCA Bill Id:AB 1286
Author:(Haney) – As Introduced Ver:February 16, 2023
SUBJECT: Pharmacy.
SUMMARY: Authorizes a pharmacist-in-charge to make staffing decisions in a pharmacy and to close a pharmacy if workplace hazards may create an unsafe environment; requires a community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services; authorizes pharmacy technicians with specified training to perform additional tasks, including administering vaccines and epinephrine, performing specimen collection for laboratory tests, and receiving verbal prescriptions; requires community pharmacies to report medication errors; and requires consulting pharmacists to complete a Surgical Clinic Self-Assessment Form every other year, among other provisions.
EXISTING LAW:
- Establishes the Pharmacy Law. (Business and Professions Code (BPC) §§ 4000 et seq.)
- Establishes the California State Board of Pharmacy (BOP) to administer and enforce the Pharmacy Law, comprised of seven pharmacists and six public members. (BPC § 4002)
- Provides that protection of the public shall be the highest priority for the BOP in exercising its licensing, regulatory, and disciplinary functions. (BPC § 4001.1)
- Authorizes the Board to adopt rules and regulations as may be necessary for the protection of the public. (BPC § 4005)
- Defines “pharmacy” as an area, place, or premises licensed by the BOP in which the profession of pharmacy is practiced and where prescriptions are compounded. (BPC § 4037)
- Defines “pharmacy technician” as an individual who assists a pharmacist in a pharmacy in the performance of their pharmacy-related duties. (BPC § 4038)
- Declares pharmacy practice to be “a dynamic, patient-oriented health service that applies a scientific body of knowledge to improve and promote patient health by means of appropriate drug use, drug-related therapy, and communication for clinical and consultative purposes” and that “pharmacy practice is continually evolving to include more sophisticated and comprehensive patient care activities.” (BPC § 4050)
- Defines “pharmacist” as a natural person to whom a license has been issued by the BOP which is required for any person to manufacture, compound, furnish, sell, or dispense a dangerous drug or dangerous device, or to dispense or compound a prescription. (BPC § 4036; BPC § 4051)
- Authorizes a pharmacist to do all of the following, among other permissible activities, as part of their scope of practice:
- Provide consultation, training, and education to patients about drug therapy, disease management, and disease prevention.
- Provide professional information, including clinical or pharmacological information, advice, or consultation to other health care professionals, and participate in multidisciplinary review of patient progress, including appropriate access to medical records.
- Order and interpret tests for the purpose of monitoring and managing the efficacy and toxicity of drug therapies in coordination with the patient’s provider or prescriber.
- Administer immunizations pursuant to a protocol with a prescriber.
- Furnish emergency contraception drug therapy, self-administered hormonal contraceptives, HIV preexposure and postexposure prophylaxis, and nicotine replacement products, subject to specified requirements.
- Administer drugs and biological products that have been ordered by a prescriber.
(BPC § 4052)
- Authorizes a pharmacist to furnish an approved opioid antagonist in accordance with standardized procedures or protocols developed and approved by the BOP and the Medical Board of California, in consultation with stakeholders. (BPC § 4052.01)
- Authorizes a pharmacist to perform skin puncture in the course of performing routine patient assessment procedures. (BPC § 4052.4)
- Authorizes a pharmacist to independently initiate and administer any vaccine that has been approved or authorized by the federal Food and Drug Administration and received a federal Advisory Committee on Immunization Practices individual vaccine recommendation published by the federal Centers for Disease Control and Prevention for persons three years of age and older. (BPC § 4052.8)
- Requires each pharmacy to designate a pharmacist-in-charge, subject to approval by the BOP, who is responsible for a pharmacy’s compliance with all state and federal laws and regulations pertaining to the practice of pharmacy. (BPC § 4113)
- Prohibits a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times. (BPC § 4113.5)
- Authorizes a pharmacy technician to perform packaging, manipulative, repetitive, or other nondiscretionary tasks only while assisting, and while under the direct supervision and control of, a pharmacist; holds the pharmacist responsible for the duties performed under his or her supervision by a technician. (BPC § 4115(a))
- Limits a pharmacy with only one pharmacist to no more than one pharmacy technician, and states that the total ratio of pharmacy technicians to any additional pharmacist shall not exceed 2:1. (BPC § 4115(f))
- Requires every pharmacy to establish a quality assurance program that shall, at a minimum, document medication errors attributable, in whole or in part, to the pharmacy or its personnel. (BPC § 4125)
- Requires clinics to retain a consulting pharmacist to approve policies and procedures and to certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of the Pharmacy Law. (BPC § 4192)
- Authorizes a pharmacist to seek recognition as an advanced practice pharmacist if they meet certain education and training requirements. (BPC § 4210)
- Provides that the BOP shall take action against any licensee who is guilty of unprofessional conduct, with various specific examples provided. (BPC § 4301)
- Subjects a licensed pharmacist to formal discipline for unprofessional conduct that includes acts or omissions that involve the following:
- Inappropriate exercise of their education, training, or experience as a pharmacist.
- The failure to exercise or implement their best professional judgment or corresponding responsibility with regard to the dispensing or furnishing of controlled substances, dangerous drugs, or dangerous devices, or the provision of services.
- The failure to consult appropriate patient, prescription, and other records pertaining to the performance of any pharmacy function.
- The failure to fully maintain and retain appropriate patient-specific information pertaining to the performance of any pharmacy function.
(BPC § 4306.5)
THIS BILL:
- Provides that the pharmacist-in-charge may make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist’s ability to practice competently and safely.
- Allows the pharmacist on duty to adjust staffing according to workload if needed and if the pharmacist-in-charge is not available.
- Authorizes the pharmacist-in-charge to close a pharmacy if workplace hazards, such as unsanitary conditions, temperatures that deviate from appropriate drug storage conditions, or other conditions that, based on their professional judgment, may create an unsafe environment for personnel or pharmacy staff.
- Allows the pharmacist on duty to close the pharmacy for the above reasons if the pharmacist-in-charge is not available.
- Authorizes the pharmacist on duty to close a pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services in a safe manner without fear of retaliation.
- Requires a community pharmacy to be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services.
- Requires scheduled closures for lunch time for all pharmacy staff to be established and publicly posted and included on the outgoing telephone message where staffing of pharmacist hours does not overlap sufficiently.
- Requires a community pharmacy to report all medication errors to an entity approved by the BOP, no later than 14 days following the date of discovery of the error, and to maintain records demonstrating compliance with this requirement for three years and to make these records immediately available at the request of an inspector.
- Exempts medication error reports from the California Public Records Act.
- Prohibits the BOP from taking disciplinary action solely based on a medication error report, unless it receives other information regarding the medication error.
- Defines “community pharmacy” as including any pharmacy that dispenses medication to an outpatient.
- Authorizes a pharmacy technician to administer vaccines, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive verbal prescriptions, receive prescription transfers, and accept clarification on prescriptions under the following conditions:
- The pharmacist-in-charge of the pharmacy at which the tasks are being performed has deemed the pharmacy technician competent to perform such tasks and documented such determination in writing.
- The pharmacy has scheduled another pharmacy technician to assist the pharmacist by performing the tasks.
- The pharmacy technician is certified by a program accredited by the National Commission for Certifying Agencies that is approved by the BOP.
- The pharmacy technician has successfully completed at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technician’s injection technique.
- Provides that a pharmacy with only one pharmacist shall have no more than one pharmacy technician performing the above additional tasks, but that a second pharmacy technician is then available to perform standard tasks, notwithstanding the Pharmacy Law’s 1:1 ratio.
- Requires the consulting pharmacist at a clinic to complete a Surgical Clinic Self-Assessment Form before July 1 of every odd-numbered year, as determined by the BOP, as a means to promote compliance through self-examination and education.
- Requires the consulting pharmacist at a clinic to certify compliance with quarterly inspection requirements and provide the most recently completed self-assessment form as part of their renewal process.
- Adds the following actions or conduct to acts that constitute unprofessional conduct by licensees, subject to discipline by the BOP:
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacist’s ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations.
- Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
- Authorizes the BOP to assess administrative fines and issue orders of abatement to any unlicensed entity who engages in any action that requires licensure under the jurisdiction of the BOP, not to exceed $5,000 for each occurrence pursuant to a citation issued by the BOP.
FISCAL EFFECT: Unknown; this bill is keyed fiscal by the Legislative Counsel.
COMMENTS:
Purpose. This bill is sponsored by the California State Board of Pharmacy. According to the author:
“Community chain pharmacies and the pharmacists who work for them are instrumental in delivering care to Californians. However, recent news reports have highlighted alarming medication errors in this setting—including errors that have led to death. The root cause of medication errors in the community chain setting can be tied to pharmacy working conditions, like insufficient staffing, unsanitary conditions, or lack of autonomy to make clinical decisions in the best interest of the patient. Unfortunately, there is no requirement under current law for pharmacies to track medication errors or to consider the pharmacy working conditions that lead to medication errors. To address the root cause of medication errors and major faults in Pharmacy Law, AB 1286 will establish a first in the nation mandatory reporting of medication errors to allow for robust evaluation of the causes of medication errors. It also gives licensed pharmacy staff autonomy over their working conditions so they can provide better patient care and services for Californians.”
Background.
Pharmacist-in-Charge Authority. Under the Pharmacy Law, pharmacists licensed by the BOP can be directly employed by the corporate owners of retailers and other community pharmacies. This has remained the case despite increasing recognition of their professional training and authority to exercise a meaningful degree of clinical judgement, which has resulted in numerous scope expansions for the profession. However, each pharmacy must designate a “pharmacist-in-charge,” subject to approval by the BOP. This pharmacist-in-charge is responsible for a pharmacy’s compliance with all state and federal laws and regulations pertaining to the practice of pharmacy.
This bill would expand the autonomy of the pharmacist-in-charge to make certain staffing and pharmacy operations decisions that the pharmacist-in-charge believes to be in the best interest of personnel and patients. First, the bill would authorize the pharmacist-in-charge to make staffing decisions to ensure sufficient personnel are present in the pharmacy to prevent fatigue, distraction, or other conditions that may interfere with a pharmacist’s ability to practice competently and safely. This authority would be delegated to the pharmacist on duty if the pharmacist-in-charge is not available.
Second, this bill would authorize the pharmacist-in-charge to close the pharmacy under certain conditions, including in circumstances where workplace hazards, such as unsanitary conditions, temperatures that deviate from appropriate drug storage conditions, or other conditions that, based on the pharmacist’s professional judgment, may create an unsafe environment for personnel or pharmacy staff. This authority would also be delegated to the pharmacist on duty if the pharmacist-in-charge is not available. The pharmacist on duty would additionally be allowed to close a community pharmacy if, in their opinion, the staffing at the pharmacy is inadequate to safely fill or dispense prescriptions or provide other patient care services in a safe manner without fear of retaliation.
Pharmacy Staffing. Pharmacists working in community pharmacies, particularly those co-located with other retail and grocery stores, have historically complained that it is common for a pharmacist to be the only employee assigned to the pharmacy area. According to previously conducted surveys, 83% of pharmacists report being left alone during the workday for an average period of four hours. Within this population, the survey indicated that a high percentage of pharmacists stated that they do not have enough time to fulfill their professional functions to the extent that they believed necessary. These pharmacists have argued that instead of providing their core pharmacy services, much of their time is instead spent performing clerical tasks and performing non-pharmacy activities on behalf of the business.
Statute authorizes an unlicensed employee to provide purely clerical assistance to a pharmacist, and for a pharmacy technician licensed by the BOP to assist a pharmacist with a number of more sensitive pharmacy service activities. The Pharmacy Law imposes a strict cap on the number of pharmacy technicians who may be assigned to assist a pharmacist; a single pharmacist may be assisted by no more than a single pharmacy technician. Many community pharmacy owners believe that this restrictive law, referred to as the “pharmacist/pharmacy technician ratio,” frequently results in inadequate staff support for pharmacists and an inability for some community pharmacies to adequately meet the demands of their patients. Several efforts to increase this ratio over the years have failed to pass.
In 2018, SB 1442 (Wiener) was enacted to prohibit community pharmacies from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless either another employee of the pharmacy or, if the pharmacy is located within another establishment, an employee of the establishment within which the pharmacy is located, is made available to assist the pharmacist at all times. An exception was included for situations where another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances, and the pharmacy takes all reasonable action to make another employee available to assist the pharmacist.
Representatives of pharmacists who work in community pharmacies have complained that the 2018 legislation has not been effectively implemented due to deficiencies in the law. These organizations report that pharmacists are often still left alone without support staff in many cases where additional staff is needed. This bill would seek to rectify this issue by expressly requiring that a community pharmacy be staffed at all times with at least one clerk or pharmacy technician fully dedicated to performing pharmacy-related services. The bill would additionally provide that where staffing of pharmacist hours does not overlap sufficiently, scheduled closures for lunch time for all pharmacy staff shall be established and publicly posted and included on the outgoing telephone message.
Pharmacy Technician Scope. Over the past several years, the BOP has voted to support the development of a legislative proposal to create a new mid-level practitioner in pharmacy settings. This proposed “advanced pharmacy technician” would be authorized to carry out certain duties that pose a relatively low risk of patient harm but may currently only be performed by pharmacists, allowing a pharmacist to spend more time engaged in patient care. While the BOP has formally pursued legislation to establish a new license category for advanced pharmacy technicians and enable these mid-level practitioners to serve in pharmacies, no legislative attempt has been successful to date.
During the COVID-19 pandemic, the Governor signed an executive order that created a new process for boards and the public to request waivers of requirements related to healing arts professional licensing through the Department of Consumer Affairs (DCA). Through this waiver process, the DCA issued multiple waivers of law to authorize various healing arts licensees to order and administer the COVID-19 vaccine. These waivers have extended to pharmacy technicians, as well as pharmacists and other healing arts professionals, consistent with the federal Public Readiness and Emergency Preparedness (PREP) Act. On August 4, 2021, the federal Health and Human Services Agency issued an amendment to the Public Readiness and Emergency Preparedness (PREP) Act to extend coverage to pharmacy technicians with proper training to administer seasonal flu vaccines to adults in addition to the COVID-19 vaccine.
This bill would authorize pharmacy technicians to administer vaccines, administer epinephrine, perform specimen collection for CLIA-waived tests, receive verbal prescriptions and prescription transfers, and accept clarification on prescriptions. The pharmacist-in-charge must first deem the pharmacy technician competent to perform those tasks and documented that determination in writing. The pharmacy technicians would also be required to complete at least six hours of practical training approved by the Accreditation Council for Pharmacy Education and includes hands-on injection technique, the recognition and treatment of emergency reactions to vaccines, and an assessment of the pharmacy technician’s injection technique. A pharmacy technician who qualifies to perform the additional tasks would then not count in the Pharmacy Law’s 1:1 ratio, and another pharmacy technician would be required to assist with other tasks.
Surgical Clinic Self-Assessment Forms. The Pharmacy Law requires certain clinics, including surgical clinics, accredited outpatient settings, and certified ambulatory surgical centers to obtain a license from the BOP. These clinics are required to retain a consulting pharmacist to approve the clinic’s policies and procedures in conjunction with the professional director and the administrator. In addition, the consulting pharmacist is required to visit the clinic regularly and at least quarterly. The consulting pharmacist is then required to certify in writing quarterly that the clinic is, or is not, operating in compliance with the requirements of the Pharmacy Law. Each completed written certification shall be kept on file in the clinic for three years and shall include recommended corrective actions, if appropriate.
This bill would additionally require each consulting pharmacist for a clinic to complete a Surgical Clinic Self-Assessment Form, as determined by the BOP, as a means to promote compliance through self-examination and education. The self-assessment is intended to assess the clinic’s compliance with current laws and regulations and include information on compounding practices as specified on the most recent version of the Surgical Clinic Self-Assessment Form approved by the BOP and posted on its website. The professional director of the clinic and consulting pharmacist would be required to certify that they have read, reviewed, and completed self-assessment to the best of their professional ability and acknowledge that failure to correct any deficiency identified could result in action by the board. The completed form would then be signed under penalty of perjury, kept on file in the clinic for three years, and made available to the BOP or its designee, upon request. This process would be required before July 1 on each odd-numbered year and would be incorporated into the consulting pharmacist’s renewal process, along with certification of compliance with quarterly inspection requirements.
Medication Errors. The BOP has listed medication error as the number one violation resulting in a citation in nearly every year within the last several years. According to the Journal of the American Medical Association, 46 percent of adults cannot understand the information listed on their prescription drug labels. Furthermore, the Institute of Medicine of the National Academies indicates that medication errors are among the most common medical errors, harming at least 1.5 million people annually.
This bill would seek to improve the state’s understanding of the causes of medication errors by requiring community pharmacies to report all medication errors to an entity approved by the BOP. A community pharmacy would be required to submit the report no later than 14 days following the date of discovery of the error. Reports would be deemed confidential and not subject to discovery, subpoena, or disclosure pursuant to the California Public Records Act. The BOP would not be allowed to subject a community pharmacy to discipline or other enforcement action based solely on the report; however, if the BOP receives other information regarding the medication error, that information may serve as basis for discipline or other enforcement by the BOP.
Unprofessional Conduct. The BOP’s Enforcement Unit regularly engages in investigations of licensees that may result in disciplinary action, as well as cases involving unlicensed activity. Over 12,100 investigations were completed from FY 2015/16 through FY 2018/19, with 1,335 referrals for formal discipline resulting in the revocation or surrender of 854 licenses and 462 licenses placed on probation. In addition, the BOP issued a total of 7,223 citations. On average, the BOP receives around 3,500 complaints per year. These complaints are then categorized into priorities based on the potential risk to public health and safety.
The Pharmacy Law requires the BOP to take action against any licensee who is guilty of unprofessional conduct. Statute provides that unprofessional conduct includes various specified acts and omissions, including incompetence, gross negligence, inappropriate furnishing of controlled substances, and other violations of law. Existing law specifies that engaging in any conduct that subverts or attempts to subvert an investigation of the BOP is unprofessional conduct.
This bill would further add to the list of what constitutes unprofessional conduct. Specifically, the bill would expressly include the following actions or conduct as examples of unprofessional conduct:
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist to comply with laws and regulations, or exercise professional judgment, including creating or allowing conditions that may interfere with a pharmacist’s ability to practice with competency and safety or creating or allowing an environment that may jeopardize patient care.
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist-in-charge to comply with laws and regulations, exercise professional judgment, or make determinations about adequate staffing levels to safely fill prescriptions of the pharmacy or provide other patient care services in a safe and competent manner.
- Actions or conduct that would subvert or tend to subvert the efforts of a pharmacist intern or and pharmacy technician to comply with laws or regulations.
- Establishing policies and procedures related to time guarantees to fill prescriptions within a specified time unless those guarantees are required by law or to meet contractual requirements.
Current Related Legislation. AB 1341 (Berman) would authorizes pharmacists to continue furnishing COVID-19 oral therapeutics to patients who test positive for SARS-CoV-2, without a prior prescription, until January 1, 2025.
SB 524 (Caballero) would authorize a pharmacist to furnish prescription medications that are furnished pursuant to the result from a test performed by the pharmacist that is used to guide diagnosis or clinical decisionmaking. This bill is pending referral in the Senate Committee on Business, Professions, and Economic Development.
Prior Related Legislation. AB 1533 (Committee on Business and Professions, Chapter 629, Statutes of 2021) extended the sunset date for the BOP until January 1, 2026 and made additional technical changes, statutory improvements, and policy reforms in response to issues raised during the BOP’s sunset review oversight process.
AB 1064 (Fong, Chapter 655, Statutes of 2021) expanded the authority of a pharmacist to initiate and administer immunizations to include any vaccine approved or authorized by the FDA for persons 3 years of age and older.
SB 362 (Newman, Chapter 334, Statutes of 2021) prohibited a community pharmacy from establishing quotas to numerically measure or evaluate a pharmacist or pharmacy technician's performance of duties requiring a license.
SB 1442 (Wiener, Chapter 569, Statutes of 2018) prohibited a community pharmacy from requiring a pharmacist employee to engage in the practice of pharmacy at any time the pharmacy is open to the public, unless another employee is made available to assist the pharmacist at all times.
ARGUMENTS IN SUPPORT:
The California State Board of Pharmacy (BOP) is sponsor of this bill. The BOP writes: “Assembly Bill 1286 is a culmination of a yearlong effort undertaken by an ad hoc committee specifically focused on evaluating medication errors, working conditions, and the intersection of the two. This committee was formed after the Board considered survey results from its own workforce survey that included some startling findings including 83% of pharmacists working in community chain pharmacies indicated they do not believe they have sufficient time to provide appropriate patient consultation, while 32% of pharmacists working in community independent pharmacies indicated same. As part of the Committee’s process, members heard from experts in the field, learned about authorities in other jurisdictions, and gained an understanding about findings and activities under way at the national level. It is incumbent upon the Board to act now on these findings to promote patient care.”
The United Food and Commercial Workers Western States Council (UFCW) supports this bill. According to UFCW: “The Board charged by law with protecting patients who need prescription medicines to stay alive, heal, and reduce suffering is telling this Legislature Californians are broadly and deeply at-risk of death and needless anguish. The cause? Nothing more than publicly traded chain pharmacies placing short-term profits over the lives of California families. This bill is one of the most important public health bills pending this year. It is based on careful study, is proportional, and, according to the expert regulator, urgently needed.”
ARGUMENTS IN OPPOSITION:
The California Community Pharmacy Coalition (CCPC), a project of the California Retailers Association, opposes this bill. In regards to the bill’s minimum staffing requirements, the CPPC writes: “Although CCPC acknowledges the benefits of having additional non-pharmacist staff in the pharmacy, there are often unforeseen circumstances, out of the pharmacy’s control, that make this impossible. For example, if there is only one technician working in the pharmacy and that technician calls in sick or is unable to make it to work on any given day, the pharmacy would have to close. We believe this is antithetical to the Board’s role of consumer protection because pharmacy closures will result in reduced access to critical medications for consumers.” In regards to the bill’s provisions authorizing a pharmacist-in-charge to close a pharmacy, the CPPC argues: “The bill, if passed, will result in unplanned and last minute pharmacy closures across the state, which will be hugely detrimental to Californians who rely on their community pharmacies for medications, testing, vaccines and other critical healthcare services. What if the pharmacy is located in a rural area and is the only place where a patient can access an emergency medication? If that pharmacy closes, that patient will be forced to go without their medication and potentially rely on the Emergency Department for care, which will cause a significant financial strain on our healthcare system.”
POLICY ISSUE(S) FOR CONSIDERATION:
Pharmacy Closures. This bill would authorize a pharmacist-in-charge or pharmacist on duty to close a pharmacy if workplace hazards “may create an unsafe environment for personnel or pharmacy staff” based on the pharmacist’s professional judgment. The bill provides “unsanitary conditions” and “temperatures that deviate from appropriate drug storage conditions” as examples of such hazards. While there is a compelling interest in ensuring that pharmacists-in-charge have the authority to act in the best interest of pharmacy staff and patients, this language is arguably overbroad and could capture conditions that technically qualify as “workplace hazards” but do not reach a level of urgency that justifies full closure of a pharmacy, which would potentially delay care to patients and restrict access to medication. The author may wish to provide greater clarification as to what constitutes a workplace hazard for purposes of the bill.
Staffing Minimums. This bill would amend legislation enacted in 2018 through the passage of SB 1442 (Wiener), which required community pharmacies to make another employee available to assist the pharmacist at all times. The author and supporters of this bill that this requirement has not alleviated staffing issues, this bill would require a minimum of one pharmacy technician or clerk to be present at the pharmacy at all times. However, it is not clear whether the exception included in SB 1442 for situations where another employee is unavailable to assist the pharmacist due to reasonably unanticipated circumstances. The author may wish to clarify that the exception for unanticipated circumstances and emergencies would still apply to this new minimum staffing requirement. The author may also wish to authorize the pharmacist on duty to waive this requirement in circumstances where additional staff is not needed based on workload.
Pharmacy Technician Scope Expansion. This bill would authorize pharmacy technicians with specified training to engage in additional acts beyond their normal scope. Specifically, the bill would allow trained pharmacy technicians to administer vaccines, administer epinephrine, perform specimen collection for tests that are classified as waived under CLIA, receive verbal prescriptions, receive prescription transfers, and accept clarification on prescriptions. Concerns have been raised that receiving verbal prescriptions does require a degree of professional judgment, considering many medications sound similar; the author may wish to consider whether including this task is appropriate for non-pharmacists. Additionally, while administering flu and COVID-19 vaccines fulfills an important public health need and pharmacy technicians were previously given emergency authorization to administer these vaccines, other vaccines may not be appropriate to include in the pharmacy technician’s expanded scope. Therefore, the author may wish to consider narrowing the bill to only include these two vaccines.
AMENDMENTS:
- To add parameters to what constitutes cause for a pharmacist-in-charge to close a pharmacy, the proposed subdivision (d) in Section 1 of the bill should be amended to read as follows:
(d) The pharmacist-in-charge may close a pharmacy under conditions that, based on the pharmacist-in-charge’s professional judgment, present an immediate risk to the health and safety of patients, personnel, or pharmacy staff. If the pharmacist-in-charge is not available, the pharmacist on duty may close the pharmacy for the reasons described in this subdivision. The pharmacist-in-charge or pharmacist on duty shall reopen the pharmacy as soon as reasonably possible upon the abatement of the condition or conditions that presented an immediate risk to the health and safety of patients. The conditions described by this subdivision may include, but are not limited to, any of the following:
(1) Workplace safety and health hazards, including those contained in Division 5 of the Labor Code.
(2) Temperatures that deviate from appropriate drug storage conditions.
(3) Other conditions that present an immediate risk to the health and safety of patients, personnel, or pharmacy staff.
- To ensure that the minimum staffing requirements added by the bill allow for exceptions when there are reasonably unanticipated circumstances or when the pharmacist on duty believes that workload needs do not necessitate support staff, add the following paragraph to the proposed subdivision (f) in Section 3 of the bill:
(3) The board shall not take action against a pharmacy for a violation of paragraph (1) if the conditions of subdivision (d) apply or if the pharmacist on duty waives the requirement in writing during specified hours based on workload needs.
- To narrow the provisions of the bill that would authorize pharmacy technicians with specified training to engage in additional acts, amend the proposed subdivision (b) in Section 4 of the bill to specify that a pharmacy technician may only administer influenza and COVID-19 vaccines, and strike reference in that subdivision to receiving verbal prescriptions.
REGISTERED SUPPORT:
California State Board of Pharmacy (Sponsor)
United Food and Commercial Workers Western States Council
REGISTERED OPPOSITION:
California Community Pharmacy Coalition
Analysis Prepared by: Robert Sumner / B. & P. / (916) 319-3301
Discussed in Hearing
Assembly Floor
Senate Floor
Senate Standing Committee on Judiciary
Senate Standing Committee on Business, Professions and Economic Development
Assembly Floor
Assembly Floor
Assembly Standing Committee on Business and Professions
Bill Author
Bill Co-Author(s):